LCD Reference Article Billing and Coding Article

Billing and Coding: Monitored Anesthesia Care

A57361

Expand All | Collapse All
Draft Article
Draft Articles are works in progress and not necessarily a reflection of the current billing and coding practices. Revisions to codes are carefully and thoroughly reviewed and are not intended to change the original intent of the LCD.

Document Note

Note History

Contractor Information

Article Information

General Information

Source Article ID
N/A
Article ID
A57361
Original ICD-9 Article ID
Not Applicable
Article Title
Billing and Coding: Monitored Anesthesia Care
Article Type
Billing and Coding
Original Effective Date
10/01/2019
Revision Effective Date
10/01/2024
Revision Ending Date
N/A
Retirement Date
N/A

CPT codes, descriptions, and other data only are copyright 2023 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.

Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

Current Dental Terminology © 2023 American Dental Association. All rights reserved.

Copyright © 2024, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA copyrighted materials contained within this publication may be copied without the express written consent of the AHA. AHA copyrighted materials including the UB‐04 codes and descriptions may not be removed, copied, or utilized within any software, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize any AHA materials, please contact the AHA at 312‐893‐6816.

Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, resale and/or to be used in any product or publication; creating any modified or derivative work of the UB‐04 Manual and/or codes and descriptions; and/or making any commercial use of UB‐04 Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an express license from the American Hospital Association. The American Hospital Association (the "AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. The views and/or positions presented in the material do not necessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its affiliates.

CMS National Coverage Policy

Social Security Act (Title XVIII) Standard References:

  • Title XVIII of the Social Security Act, Section 1833(e) states that no payment shall be made to any provider of services or other person under this part unless there has been furnished such information as may be necessary in order to determine the amounts due such provider or other person under this part for the period with respect to which the amounts are being paid or for any prior period.

Article Guidance

Article Text

This Billing and Coding Article provides billing and coding guidance for Local Coverage Determination (LCD) L35049, Monitored Anesthesia Care. Please refer to the LCD for reasonable and necessary requirements.

Coding Guidance

Notice:
It is not appropriate to bill Medicare for services that are not covered (as described by the entire LCD) as if they are covered. When billing for non-covered services, use the appropriate modifier.

Anesthesia procedures listed in the “CPT/HCPCS Codes” section of this article are examples of those that are usually provided by the attending surgeon and are included in the global fee and are not separately billable. In certain instances, however, MAC provided by anesthesia personnel may be necessary for these procedures if the patient has one or more of the conditions or situations found in the “ICD-10-CM Codes That Support Medical Necessity” section of this article. The use of anesthesia modifiers, when the CPT code is not fully descriptive, is required as follows:

  • G8 anesthesia modifier – used to indicate certain deep, complex, complicated, or markedly invasive surgical procedures. This modifier is to be applied to the following anesthesia codes only: 00100, 00300, 00400, 00160, 00532 and 00920.
  • G9 anesthesia modifier – represents “a history of severe cardiopulmonary disease” and should be utilized whenever the proceduralist feels the need for MAC due to a history of advanced cardiopulmonary disease. The documentation of this clinical decision-making process and the need for additional monitoring must be clearly documented in the medical record.
  • Anesthesia codes utilized to indicate the clinical condition of the patient receiving MAC: P1 – healthy individual with minimal anesthesia risk, P2 – mild systemic disease, P3 – severe systemic disease with intermittent threat of morbidity or mortality, P4 – severe systemic illness with ongoing threat of morbidity or mortality, P5 – premorbid condition with high risk of demise unless procedural intervention is performed.

Special conditions or criteria must be supported by documentation in the medical record.

Conditions listed under the “Diagnoses that Support Medical Necessity” section of this article, if matched with anesthesia procedures in the “CPT/HCPCS Codes” section of the article, could support the need for MAC. Other disease states can also be considered if medical justification is demonstrated.


Diagnoses that Support Medical Necessity

Additional diagnoses that do not have a fully descriptive ICD-10-CM code are listed below. By using the diagnosis code(s) listed, the medical records must reflect the conditions as described.

  • For combative patients, use ICD-10-CM code F91.9.
  • For patients with low pain thresholds or who suffer severe pain, use ICD-10-CM code G97.81.
  • For intraoperative expansion of procedure, use ICD-10-CM code T81.9XXA.
  • For any condition in a pediatric patient, Medicare eligible and younger than 18 years of age, use ICD-10-CM code T88.8XXA.
  • For patients with mental retardation (patients who are uncooperative due to a lack of understanding caused by their mental disability), use ICD-10-CM code F79.

If MAC is used for these reasons, clinical records must be available upon request that justify the need for MAC.

Documentation Requirements

  1. All documentation must be maintained in the patient's medical record and made available to the contractor upon request.
  2. Every page of the record must be legible and include appropriate patient identification information (e.g., complete name, dates of service[s]). The documentation must include the legible signature of the physician or non-physician practitioner responsible for and providing the care to the patient.
  3. The submitted medical record must support the use of the selected ICD-10-CM code(s). The submitted CPT/HCPCS code must describe the service performed.

Response To Comments

Number Comment Response
1
N/A

Coding Information

Bill Type Codes

Code Description

Please accept the License to see the codes.

N/A

Revenue Codes

Code Description

Please accept the License to see the codes.

N/A

CPT/HCPCS Codes

Please accept the License to see the codes.

N/A

CPT/HCPCS Modifiers

Group 1

Group 1 Paragraph

The procedures listed above represent commonly used anesthesia codes that may involve MAC. When these codes are used and MAC has been provided, the QS modifier must be used.

Group 1 Codes

N/A

N/A

ICD-10-CM Codes that Support Medical Necessity

Group 1

(1,987 Codes)
Group 1 Paragraph

It is the provider’s responsibility to select codes carried out to the highest level of specificity and selected from the ICD-10-CM code book appropriate to the year in which the service is rendered for the claim(s) submitted.

The following ICD-10-CM codes support medical necessity and provide coverage for CPT/HCPCS codes: 00100, 00124, 00148, 00160, 00164, 00300, 00322, 00400, 00410, 00454, 00520, 00522, 00524, 00530, 00532, 00635, 00640, 00702, 00731, 00732, 00842, 00920, 00921, 01130, 01380, 01420, 01490, 01680, 01730, 01780, 01782, 01820, 01829, 01860, 01916, 01920, 01922, 01930, 01937, 01938, 01939, 01940, 01941, 01942, 01991, 01992, and 01999.

Group 1 Codes
Code Description
A40.3 Sepsis due to Streptococcus pneumoniae
A40.9 Streptococcal sepsis, unspecified
A41.01 Sepsis due to Methicillin susceptible Staphylococcus aureus
A41.02 Sepsis due to Methicillin resistant Staphylococcus aureus
A41.1 Sepsis due to other specified staphylococcus
A41.2 Sepsis due to unspecified staphylococcus
A41.3 Sepsis due to Hemophilus influenzae
A41.4 Sepsis due to anaerobes
A41.50 Gram-negative sepsis, unspecified
A41.51 Sepsis due to Escherichia coli [E. coli]
A41.52 Sepsis due to Pseudomonas
A41.53 Sepsis due to Serratia
A41.54 Sepsis due to Acinetobacter baumannii
A41.59 Other Gram-negative sepsis
A41.89* Other specified sepsis
A41.9* Sepsis, unspecified organism
E00.0 Congenital iodine-deficiency syndrome, neurological type
E00.1 Congenital iodine-deficiency syndrome, myxedematous type
E00.2 Congenital iodine-deficiency syndrome, mixed type
E00.9 Congenital iodine-deficiency syndrome, unspecified
E01.8 Other iodine-deficiency related thyroid disorders and allied conditions
E02 Subclinical iodine-deficiency hypothyroidism
E03.0 Congenital hypothyroidism with diffuse goiter
E03.1 Congenital hypothyroidism without goiter
E03.2 Hypothyroidism due to medicaments and other exogenous substances
E03.3 Postinfectious hypothyroidism
E03.8 Other specified hypothyroidism
E03.9 Hypothyroidism, unspecified
E05.00 Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm
E05.01 Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm
E05.10 Thyrotoxicosis with toxic single thyroid nodule without thyrotoxic crisis or storm
E05.11 Thyrotoxicosis with toxic single thyroid nodule with thyrotoxic crisis or storm
E05.20 Thyrotoxicosis with toxic multinodular goiter without thyrotoxic crisis or storm
E05.21 Thyrotoxicosis with toxic multinodular goiter with thyrotoxic crisis or storm
E05.30 Thyrotoxicosis from ectopic thyroid tissue without thyrotoxic crisis or storm
E05.31 Thyrotoxicosis from ectopic thyroid tissue with thyrotoxic crisis or storm
E05.40 Thyrotoxicosis factitia without thyrotoxic crisis or storm
E05.41 Thyrotoxicosis factitia with thyrotoxic crisis or storm
E05.80 Other thyrotoxicosis without thyrotoxic crisis or storm
E05.81 Other thyrotoxicosis with thyrotoxic crisis or storm
E05.90 Thyrotoxicosis, unspecified without thyrotoxic crisis or storm
E05.91 Thyrotoxicosis, unspecified with thyrotoxic crisis or storm
E10.10 Type 1 diabetes mellitus with ketoacidosis without coma
E10.11 Type 1 diabetes mellitus with ketoacidosis with coma
E10.21 Type 1 diabetes mellitus with diabetic nephropathy
E10.22 Type 1 diabetes mellitus with diabetic chronic kidney disease
E10.29 Type 1 diabetes mellitus with other diabetic kidney complication
E10.311 Type 1 diabetes mellitus with unspecified diabetic retinopathy with macular edema
E10.319 Type 1 diabetes mellitus with unspecified diabetic retinopathy without macular edema
E10.36 Type 1 diabetes mellitus with diabetic cataract
E10.39 Type 1 diabetes mellitus with other diabetic ophthalmic complication
E10.40 Type 1 diabetes mellitus with diabetic neuropathy, unspecified
E10.49 Type 1 diabetes mellitus with other diabetic neurological complication
E10.51 Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene
E10.59 Type 1 diabetes mellitus with other circulatory complications
E10.618 Type 1 diabetes mellitus with other diabetic arthropathy
E10.620 Type 1 diabetes mellitus with diabetic dermatitis
E10.621 Type 1 diabetes mellitus with foot ulcer
E10.622 Type 1 diabetes mellitus with other skin ulcer
E10.628 Type 1 diabetes mellitus with other skin complications
E10.630 Type 1 diabetes mellitus with periodontal disease
E10.638 Type 1 diabetes mellitus with other oral complications
E10.641 Type 1 diabetes mellitus with hypoglycemia with coma
E10.649 Type 1 diabetes mellitus with hypoglycemia without coma
E10.65 Type 1 diabetes mellitus with hyperglycemia
E10.69 Type 1 diabetes mellitus with other specified complication
E10.8 Type 1 diabetes mellitus with unspecified complications
E10.9 Type 1 diabetes mellitus without complications
E11.00 Type 2 diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
E11.01 Type 2 diabetes mellitus with hyperosmolarity with coma
E11.10 Type 2 diabetes mellitus with ketoacidosis without coma
E11.11 Type 2 diabetes mellitus with ketoacidosis with coma
E11.21 Type 2 diabetes mellitus with diabetic nephropathy
E11.22 Type 2 diabetes mellitus with diabetic chronic kidney disease
E11.29 Type 2 diabetes mellitus with other diabetic kidney complication
E11.311 Type 2 diabetes mellitus with unspecified diabetic retinopathy with macular edema
E11.319 Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema
E11.36 Type 2 diabetes mellitus with diabetic cataract
E11.39 Type 2 diabetes mellitus with other diabetic ophthalmic complication
E11.40 Type 2 diabetes mellitus with diabetic neuropathy, unspecified
E11.49 Type 2 diabetes mellitus with other diabetic neurological complication
E11.51 Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene
E11.59 Type 2 diabetes mellitus with other circulatory complications
E11.618 Type 2 diabetes mellitus with other diabetic arthropathy
E11.620 Type 2 diabetes mellitus with diabetic dermatitis
E11.621 Type 2 diabetes mellitus with foot ulcer
E11.622 Type 2 diabetes mellitus with other skin ulcer
E11.628 Type 2 diabetes mellitus with other skin complications
E11.630 Type 2 diabetes mellitus with periodontal disease
E11.638 Type 2 diabetes mellitus with other oral complications
E11.641 Type 2 diabetes mellitus with hypoglycemia with coma
E11.649 Type 2 diabetes mellitus with hypoglycemia without coma
E11.65 Type 2 diabetes mellitus with hyperglycemia
E11.69 Type 2 diabetes mellitus with other specified complication
E11.8 Type 2 diabetes mellitus with unspecified complications
E11.9 Type 2 diabetes mellitus without complications
E13.00 Other specified diabetes mellitus with hyperosmolarity without nonketotic hyperglycemic-hyperosmolar coma (NKHHC)
E13.01 Other specified diabetes mellitus with hyperosmolarity with coma
E13.10 Other specified diabetes mellitus with ketoacidosis without coma
E13.11 Other specified diabetes mellitus with ketoacidosis with coma
E13.21 Other specified diabetes mellitus with diabetic nephropathy
E13.22 Other specified diabetes mellitus with diabetic chronic kidney disease
E13.29 Other specified diabetes mellitus with other diabetic kidney complication
E13.39 Other specified diabetes mellitus with other diabetic ophthalmic complication
E13.40 Other specified diabetes mellitus with diabetic neuropathy, unspecified
E13.49 Other specified diabetes mellitus with other diabetic neurological complication
E13.59 Other specified diabetes mellitus with other circulatory complications
E13.620 Other specified diabetes mellitus with diabetic dermatitis
E13.621 Other specified diabetes mellitus with foot ulcer
E13.622 Other specified diabetes mellitus with other skin ulcer
E13.628 Other specified diabetes mellitus with other skin complications
E13.638 Other specified diabetes mellitus with other oral complications
E13.641 Other specified diabetes mellitus with hypoglycemia with coma
E13.649 Other specified diabetes mellitus with hypoglycemia without coma
E13.65 Other specified diabetes mellitus with hyperglycemia
E13.69 Other specified diabetes mellitus with other specified complication
E13.8 Other specified diabetes mellitus with unspecified complications
E13.9 Other specified diabetes mellitus without complications
E15 Nondiabetic hypoglycemic coma
E16.0 Drug-induced hypoglycemia without coma
E16.1 Other hypoglycemia
E16.2 Hypoglycemia, unspecified
E16.3 Increased secretion of glucagon
E16.4 Increased secretion of gastrin
E16.8 Other specified disorders of pancreatic internal secretion
E16.9 Disorder of pancreatic internal secretion, unspecified
E16.A1 Hypoglycemia level 1
E16.A2 Hypoglycemia level 2
E16.A3 Hypoglycemia level 3
E20.0 Idiopathic hypoparathyroidism
E20.810 Autosomal dominant hypocalcemia
E20.811 Secondary hypoparathyroidism in diseases classified elsewhere
E20.812 Autoimmune hypoparathyroidism
E20.818 Other specified hypoparathyroidism due to impaired parathyroid hormone secretion
E20.89 Other specified hypoparathyroidism
E20.9 Hypoparathyroidism, unspecified
E21.0 Primary hyperparathyroidism
E21.1 Secondary hyperparathyroidism, not elsewhere classified
E21.2 Other hyperparathyroidism
E21.3 Hyperparathyroidism, unspecified
E21.4 Other specified disorders of parathyroid gland
E21.5 Disorder of parathyroid gland, unspecified
E22.0 Acromegaly and pituitary gigantism
E22.1 Hyperprolactinemia
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
E22.8 Other hyperfunction of pituitary gland
E22.9 Hyperfunction of pituitary gland, unspecified
E23.0 Hypopituitarism
E23.1 Drug-induced hypopituitarism
E23.2 Diabetes insipidus
E23.3 Hypothalamic dysfunction, not elsewhere classified
E23.6 Other disorders of pituitary gland
E23.7 Disorder of pituitary gland, unspecified
E24.0 Pituitary-dependent Cushing's disease
E24.1 Nelson's syndrome
E24.2 Drug-induced Cushing's syndrome
E24.3 Ectopic ACTH syndrome
E24.4 Alcohol-induced pseudo-Cushing's syndrome
E24.8 Other Cushing's syndrome
E24.9 Cushing's syndrome, unspecified
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
E25.8 Other adrenogenital disorders
E25.9 Adrenogenital disorder, unspecified
E26.01 Conn's syndrome
E26.02 Glucocorticoid-remediable aldosteronism
E26.09 Other primary hyperaldosteronism
E26.1 Secondary hyperaldosteronism
E26.81 Bartter's syndrome
E26.89 Other hyperaldosteronism
E26.9 Hyperaldosteronism, unspecified
E27.0 Other adrenocortical overactivity
E27.1 Primary adrenocortical insufficiency
E27.2 Addisonian crisis
E27.3 Drug-induced adrenocortical insufficiency
E27.40 Unspecified adrenocortical insufficiency
E27.49 Other adrenocortical insufficiency
E27.5 Adrenomedullary hyperfunction
E27.8* Other specified disorders of adrenal gland
E27.9* Disorder of adrenal gland, unspecified
E32.0 Persistent hyperplasia of thymus
E32.1 Abscess of thymus
E32.8 Other diseases of thymus
E32.9 Disease of thymus, unspecified
E34.4 Constitutional tall stature
E35* Disorders of endocrine glands in diseases classified elsewhere
E66.01* Morbid (severe) obesity due to excess calories
E66.2 Morbid (severe) obesity with alveolar hypoventilation
E66.813* Obesity, class 3
E84.0* Cystic fibrosis with pulmonary manifestations
E84.11* Meconium ileus in cystic fibrosis
E84.9* Cystic fibrosis, unspecified
E86.0 Dehydration
E86.1 Hypovolemia
E86.9 Volume depletion, unspecified
E87.0 Hyperosmolality and hypernatremia
E87.1 Hypo-osmolality and hyponatremia
E87.20 Acidosis, unspecified
E87.21 Acute metabolic acidosis
E87.22 Chronic metabolic acidosis
E87.29 Other acidosis
E87.3 Alkalosis
E87.4 Mixed disorder of acid-base balance
E87.5* Hyperkalemia
E87.6* Hypokalemia
E87.70 Fluid overload, unspecified
E87.71 Transfusion associated circulatory overload
E87.79 Other fluid overload
E87.8* Other disorders of electrolyte and fluid balance, not elsewhere classified
E89.0 Postprocedural hypothyroidism
E89.1 Postprocedural hypoinsulinemia
E89.2 Postprocedural hypoparathyroidism
E89.3 Postprocedural hypopituitarism
E89.6 Postprocedural adrenocortical (-medullary) hypofunction
F01.50 Vascular dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
F01.511 Vascular dementia, unspecified severity, with agitation
F01.518 Vascular dementia, unspecified severity, with other behavioral disturbance
F01.52 Vascular dementia, unspecified severity, with psychotic disturbance
F01.53 Vascular dementia, unspecified severity, with mood disturbance
F01.54 Vascular dementia, unspecified severity, with anxiety
F01.A0 Vascular dementia, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
F01.A11 Vascular dementia, mild, with agitation
F01.A18 Vascular dementia, mild, with other behavioral disturbance
F01.A2 Vascular dementia, mild, with psychotic disturbance
F01.A3 Vascular dementia, mild, with mood disturbance
F01.A4 Vascular dementia, mild, with anxiety
F01.B0 Vascular dementia, moderate, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
F01.B11 Vascular dementia, moderate, with agitation
F01.B18 Vascular dementia, moderate, with other behavioral disturbance
F01.B2 Vascular dementia, moderate, with psychotic disturbance
F01.B3 Vascular dementia, moderate, with mood disturbance
F01.B4 Vascular dementia, moderate, with anxiety
F01.C0 Vascular dementia, severe, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
F01.C11 Vascular dementia, severe, with agitation
F01.C18 Vascular dementia, severe, with other behavioral disturbance
F01.C2 Vascular dementia, severe, with psychotic disturbance
F01.C3 Vascular dementia, severe, with mood disturbance
F01.C4 Vascular dementia, severe, with anxiety
F02.80 Dementia in other diseases classified elsewhere, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
F02.811 Dementia in other diseases classified elsewhere, unspecified severity, with agitation
F02.818 Dementia in other diseases classified elsewhere, unspecified severity, with other behavioral disturbance
F02.82 Dementia in other diseases classified elsewhere, unspecified severity, with psychotic disturbance
F02.83 Dementia in other diseases classified elsewhere, unspecified severity, with mood disturbance
F02.84 Dementia in other diseases classified elsewhere, unspecified severity, with anxiety
F02.A0 Dementia in other diseases classified elsewhere, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
F02.A11 Dementia in other diseases classified elsewhere, mild, with agitation
F02.A18 Dementia in other diseases classified elsewhere, mild, with other behavioral disturbance
F02.A2 Dementia in other diseases classified elsewhere, mild, with psychotic disturbance
F02.A3 Dementia in other diseases classified elsewhere, mild, with mood disturbance
F02.A4 Dementia in other diseases classified elsewhere, mild, with anxiety
F02.B0 Dementia in other diseases classified elsewhere, moderate, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
F02.B11 Dementia in other diseases classified elsewhere, moderate, with agitation
F02.B18 Dementia in other diseases classified elsewhere, moderate, with other behavioral disturbance
F02.B2 Dementia in other diseases classified elsewhere, moderate, with psychotic disturbance
F02.B3 Dementia in other diseases classified elsewhere, moderate, with mood disturbance
F02.B4 Dementia in other diseases classified elsewhere, moderate, with anxiety
F02.C0 Dementia in other diseases classified elsewhere, severe, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
F02.C11 Dementia in other diseases classified elsewhere, severe, with agitation
F02.C18 Dementia in other diseases classified elsewhere, severe, with other behavioral disturbance
F02.C2 Dementia in other diseases classified elsewhere, severe, with psychotic disturbance
F02.C3 Dementia in other diseases classified elsewhere, severe, with mood disturbance
F02.C4 Dementia in other diseases classified elsewhere, severe, with anxiety
F03.90 Unspecified dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
F03.911 Unspecified dementia, unspecified severity, with agitation
F03.918 Unspecified dementia, unspecified severity, with other behavioral disturbance
F03.92 Unspecified dementia, unspecified severity, with psychotic disturbance
F03.93 Unspecified dementia, unspecified severity, with mood disturbance
F03.94 Unspecified dementia, unspecified severity, with anxiety
F03.A0 Unspecified dementia, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
F03.A11 Unspecified dementia, mild, with agitation
F03.A18 Unspecified dementia, mild, with other behavioral disturbance
F03.A2 Unspecified dementia, mild, with psychotic disturbance
F03.A3 Unspecified dementia, mild, with mood disturbance
F03.A4 Unspecified dementia, mild, with anxiety
F03.B0 Unspecified dementia, moderate, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
F03.B11 Unspecified dementia, moderate, with agitation
F03.B18 Unspecified dementia, moderate, with other behavioral disturbance
F03.B2 Unspecified dementia, moderate, with psychotic disturbance
F03.B3 Unspecified dementia, moderate, with mood disturbance
F03.B4 Unspecified dementia, moderate, with anxiety
F03.C0 Unspecified dementia, severe, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety
F03.C11 Unspecified dementia, severe, with agitation
F03.C18 Unspecified dementia, severe, with other behavioral disturbance
F03.C2 Unspecified dementia, severe, with psychotic disturbance
F03.C3 Unspecified dementia, severe, with mood disturbance
F03.C4 Unspecified dementia, severe, with anxiety
F04 Amnestic disorder due to known physiological condition
F05 Delirium due to known physiological condition
F06.0 Psychotic disorder with hallucinations due to known physiological condition
F06.1 Catatonic disorder due to known physiological condition
F06.2 Psychotic disorder with delusions due to known physiological condition
F06.30 Mood disorder due to known physiological condition, unspecified
F06.31 Mood disorder due to known physiological condition with depressive features
F06.32 Mood disorder due to known physiological condition with major depressive-like episode
F06.33 Mood disorder due to known physiological condition with manic features
F06.34 Mood disorder due to known physiological condition with mixed features
F06.4 Anxiety disorder due to known physiological condition
F06.8 Other specified mental disorders due to known physiological condition
F10.10* Alcohol abuse, uncomplicated
F10.120* Alcohol abuse with intoxication, uncomplicated
F10.121 Alcohol abuse with intoxication delirium
F10.129* Alcohol abuse with intoxication, unspecified
F10.14 Alcohol abuse with alcohol-induced mood disorder
F10.150 Alcohol abuse with alcohol-induced psychotic disorder with delusions
F10.151 Alcohol abuse with alcohol-induced psychotic disorder with hallucinations
F10.159 Alcohol abuse with alcohol-induced psychotic disorder, unspecified
F10.180 Alcohol abuse with alcohol-induced anxiety disorder
F10.181 Alcohol abuse with alcohol-induced sexual dysfunction
F10.188 Alcohol abuse with other alcohol-induced disorder
F10.19 Alcohol abuse with unspecified alcohol-induced disorder
F10.221 Alcohol dependence with intoxication delirium
F10.230 Alcohol dependence with withdrawal, uncomplicated
F10.231 Alcohol dependence with withdrawal delirium
F10.232 Alcohol dependence with withdrawal with perceptual disturbance
F10.239 Alcohol dependence with withdrawal, unspecified
F10.24 Alcohol dependence with alcohol-induced mood disorder
F10.250 Alcohol dependence with alcohol-induced psychotic disorder with delusions
F10.251 Alcohol dependence with alcohol-induced psychotic disorder with hallucinations
F10.259 Alcohol dependence with alcohol-induced psychotic disorder, unspecified
F10.26 Alcohol dependence with alcohol-induced persisting amnestic disorder
F10.27 Alcohol dependence with alcohol-induced persisting dementia
F10.280 Alcohol dependence with alcohol-induced anxiety disorder
F10.281 Alcohol dependence with alcohol-induced sexual dysfunction
F10.288 Alcohol dependence with other alcohol-induced disorder
F10.29 Alcohol dependence with unspecified alcohol-induced disorder
F10.920 Alcohol use, unspecified with intoxication, uncomplicated
F10.921 Alcohol use, unspecified with intoxication delirium
F10.929 Alcohol use, unspecified with intoxication, unspecified
F10.94 Alcohol use, unspecified with alcohol-induced mood disorder
F10.950 Alcohol use, unspecified with alcohol-induced psychotic disorder with delusions
F10.951 Alcohol use, unspecified with alcohol-induced psychotic disorder with hallucinations
F10.959 Alcohol use, unspecified with alcohol-induced psychotic disorder, unspecified
F10.96 Alcohol use, unspecified with alcohol-induced persisting amnestic disorder
F10.97 Alcohol use, unspecified with alcohol-induced persisting dementia
F10.980 Alcohol use, unspecified with alcohol-induced anxiety disorder
F10.981 Alcohol use, unspecified with alcohol-induced sexual dysfunction
F10.988 Alcohol use, unspecified with other alcohol-induced disorder
F10.99 Alcohol use, unspecified with unspecified alcohol-induced disorder
F11.10 Opioid abuse, uncomplicated
F11.120 Opioid abuse with intoxication, uncomplicated
F11.121 Opioid abuse with intoxication delirium
F11.122 Opioid abuse with intoxication with perceptual disturbance
F11.129 Opioid abuse with intoxication, unspecified
F11.14 Opioid abuse with opioid-induced mood disorder
F11.150 Opioid abuse with opioid-induced psychotic disorder with delusions
F11.151 Opioid abuse with opioid-induced psychotic disorder with hallucinations
F11.159 Opioid abuse with opioid-induced psychotic disorder, unspecified
F11.181 Opioid abuse with opioid-induced sexual dysfunction
F11.188 Opioid abuse with other opioid-induced disorder
F11.19 Opioid abuse with unspecified opioid-induced disorder
F11.20 Opioid dependence, uncomplicated
F11.21 Opioid dependence, in remission
F11.222 Opioid dependence with intoxication with perceptual disturbance
F11.259 Opioid dependence with opioid-induced psychotic disorder, unspecified
F11.281 Opioid dependence with opioid-induced sexual dysfunction
F11.288 Opioid dependence with other opioid-induced disorder
F11.90 Opioid use, unspecified, uncomplicated
F11.920 Opioid use, unspecified with intoxication, uncomplicated
F11.921 Opioid use, unspecified with intoxication delirium
F11.922 Opioid use, unspecified with intoxication with perceptual disturbance
F11.929 Opioid use, unspecified with intoxication, unspecified
F11.93 Opioid use, unspecified with withdrawal
F11.94 Opioid use, unspecified with opioid-induced mood disorder
F11.950 Opioid use, unspecified with opioid-induced psychotic disorder with delusions
F11.951 Opioid use, unspecified with opioid-induced psychotic disorder with hallucinations
F11.959 Opioid use, unspecified with opioid-induced psychotic disorder, unspecified
F11.981 Opioid use, unspecified with opioid-induced sexual dysfunction
F11.988 Opioid use, unspecified with other opioid-induced disorder
F11.99 Opioid use, unspecified with unspecified opioid-induced disorder
F12.10 Cannabis abuse, uncomplicated
F12.120 Cannabis abuse with intoxication, uncomplicated
F12.121 Cannabis abuse with intoxication delirium
F12.122 Cannabis abuse with intoxication with perceptual disturbance
F12.129 Cannabis abuse with intoxication, unspecified
F12.150 Cannabis abuse with psychotic disorder with delusions
F12.151 Cannabis abuse with psychotic disorder with hallucinations
F12.159 Cannabis abuse with psychotic disorder, unspecified
F12.180 Cannabis abuse with cannabis-induced anxiety disorder
F12.188 Cannabis abuse with other cannabis-induced disorder
F12.19 Cannabis abuse with unspecified cannabis-induced disorder
F12.20 Cannabis dependence, uncomplicated
F12.21 Cannabis dependence, in remission
F12.222 Cannabis dependence with intoxication with perceptual disturbance
F12.23 Cannabis dependence with withdrawal
F12.259 Cannabis dependence with psychotic disorder, unspecified
F12.280 Cannabis dependence with cannabis-induced anxiety disorder
F12.288 Cannabis dependence with other cannabis-induced disorder
F12.90 Cannabis use, unspecified, uncomplicated
F12.920 Cannabis use, unspecified with intoxication, uncomplicated
F12.921 Cannabis use, unspecified with intoxication delirium
F12.922 Cannabis use, unspecified with intoxication with perceptual disturbance
F12.929 Cannabis use, unspecified with intoxication, unspecified
F12.93 Cannabis use, unspecified with withdrawal
F12.950 Cannabis use, unspecified with psychotic disorder with delusions
F12.951 Cannabis use, unspecified with psychotic disorder with hallucinations
F12.959 Cannabis use, unspecified with psychotic disorder, unspecified
F12.980 Cannabis use, unspecified with anxiety disorder
F12.988 Cannabis use, unspecified with other cannabis-induced disorder
F12.99 Cannabis use, unspecified with unspecified cannabis-induced disorder
F13.10 Sedative, hypnotic or anxiolytic abuse, uncomplicated
F13.120 Sedative, hypnotic or anxiolytic abuse with intoxication, uncomplicated
F13.121 Sedative, hypnotic or anxiolytic abuse with intoxication delirium
F13.129 Sedative, hypnotic or anxiolytic abuse with intoxication, unspecified
F13.14 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced mood disorder
F13.150 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions
F13.151 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations
F13.159 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified
F13.180 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder
F13.181 Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction
F13.188 Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorder
F13.19 Sedative, hypnotic or anxiolytic abuse with unspecified sedative, hypnotic or anxiolytic-induced disorder
F13.20 Sedative, hypnotic or anxiolytic dependence, uncomplicated
F13.21 Sedative, hypnotic or anxiolytic dependence, in remission
F13.259 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified
F13.280 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced anxiety disorder
F13.281 Sedative, hypnotic or anxiolytic dependence with sedative, hypnotic or anxiolytic-induced sexual dysfunction
F13.288 Sedative, hypnotic or anxiolytic dependence with other sedative, hypnotic or anxiolytic-induced disorder
F13.90 Sedative, hypnotic, or anxiolytic use, unspecified, uncomplicated
F13.920 Sedative, hypnotic or anxiolytic use, unspecified with intoxication, uncomplicated
F13.921 Sedative, hypnotic or anxiolytic use, unspecified with intoxication delirium
F13.929 Sedative, hypnotic or anxiolytic use, unspecified with intoxication, unspecified
F13.930 Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, uncomplicated
F13.931 Sedative, hypnotic or anxiolytic use, unspecified with withdrawal delirium
F13.932 Sedative, hypnotic or anxiolytic use, unspecified with withdrawal with perceptual disturbances
F13.939 Sedative, hypnotic or anxiolytic use, unspecified with withdrawal, unspecified
F13.94 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced mood disorder
F13.950 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with delusions
F13.951 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder with hallucinations
F13.959 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified
F13.96 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting amnestic disorder
F13.97 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced persisting dementia
F13.980 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced anxiety disorder
F13.981 Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sexual dysfunction
F13.988 Sedative, hypnotic or anxiolytic use, unspecified with other sedative, hypnotic or anxiolytic-induced disorder
F13.99 Sedative, hypnotic or anxiolytic use, unspecified with unspecified sedative, hypnotic or anxiolytic-induced disorder
F14.10 Cocaine abuse, uncomplicated
F14.120 Cocaine abuse with intoxication, uncomplicated
F14.121 Cocaine abuse with intoxication with delirium
F14.122 Cocaine abuse with intoxication with perceptual disturbance
F14.129 Cocaine abuse with intoxication, unspecified
F14.14 Cocaine abuse with cocaine-induced mood disorder
F14.150 Cocaine abuse with cocaine-induced psychotic disorder with delusions
F14.151 Cocaine abuse with cocaine-induced psychotic disorder with hallucinations
F14.159 Cocaine abuse with cocaine-induced psychotic disorder, unspecified
F14.180 Cocaine abuse with cocaine-induced anxiety disorder
F14.181 Cocaine abuse with cocaine-induced sexual dysfunction
F14.188 Cocaine abuse with other cocaine-induced disorder
F14.19 Cocaine abuse with unspecified cocaine-induced disorder
F14.20 Cocaine dependence, uncomplicated
F14.21 Cocaine dependence, in remission
F14.222 Cocaine dependence with intoxication with perceptual disturbance
F14.259 Cocaine dependence with cocaine-induced psychotic disorder, unspecified
F14.280 Cocaine dependence with cocaine-induced anxiety disorder
F14.281 Cocaine dependence with cocaine-induced sexual dysfunction
F14.288 Cocaine dependence with other cocaine-induced disorder
F14.90 Cocaine use, unspecified, uncomplicated
F14.920 Cocaine use, unspecified with intoxication, uncomplicated
F14.921 Cocaine use, unspecified with intoxication delirium
F14.922 Cocaine use, unspecified with intoxication with perceptual disturbance
F14.929 Cocaine use, unspecified with intoxication, unspecified
F14.94 Cocaine use, unspecified with cocaine-induced mood disorder
F14.950 Cocaine use, unspecified with cocaine-induced psychotic disorder with delusions
F14.951 Cocaine use, unspecified with cocaine-induced psychotic disorder with hallucinations
F14.959 Cocaine use, unspecified with cocaine-induced psychotic disorder, unspecified
F14.980 Cocaine use, unspecified with cocaine-induced anxiety disorder
F14.981 Cocaine use, unspecified with cocaine-induced sexual dysfunction
F14.988 Cocaine use, unspecified with other cocaine-induced disorder
F14.99 Cocaine use, unspecified with unspecified cocaine-induced disorder
F15.10 Other stimulant abuse, uncomplicated
F15.120 Other stimulant abuse with intoxication, uncomplicated
F15.121 Other stimulant abuse with intoxication delirium
F15.122 Other stimulant abuse with intoxication with perceptual disturbance
F15.129 Other stimulant abuse with intoxication, unspecified
F15.14 Other stimulant abuse with stimulant-induced mood disorder
F15.150 Other stimulant abuse with stimulant-induced psychotic disorder with delusions
F15.151 Other stimulant abuse with stimulant-induced psychotic disorder with hallucinations
F15.159 Other stimulant abuse with stimulant-induced psychotic disorder, unspecified
F15.180 Other stimulant abuse with stimulant-induced anxiety disorder
F15.181 Other stimulant abuse with stimulant-induced sexual dysfunction
F15.188 Other stimulant abuse with other stimulant-induced disorder
F15.19 Other stimulant abuse with unspecified stimulant-induced disorder
F15.20 Other stimulant dependence, uncomplicated
F15.21 Other stimulant dependence, in remission
F15.222 Other stimulant dependence with intoxication with perceptual disturbance
F15.259 Other stimulant dependence with stimulant-induced psychotic disorder, unspecified
F15.280 Other stimulant dependence with stimulant-induced anxiety disorder
F15.281 Other stimulant dependence with stimulant-induced sexual dysfunction
F15.288 Other stimulant dependence with other stimulant-induced disorder
F15.90 Other stimulant use, unspecified, uncomplicated
F15.920 Other stimulant use, unspecified with intoxication, uncomplicated
F15.921 Other stimulant use, unspecified with intoxication delirium
F15.922 Other stimulant use, unspecified with intoxication with perceptual disturbance
F15.929 Other stimulant use, unspecified with intoxication, unspecified
F15.93 Other stimulant use, unspecified with withdrawal
F15.94 Other stimulant use, unspecified with stimulant-induced mood disorder
F15.950 Other stimulant use, unspecified with stimulant-induced psychotic disorder with delusions
F15.951 Other stimulant use, unspecified with stimulant-induced psychotic disorder with hallucinations
F15.959 Other stimulant use, unspecified with stimulant-induced psychotic disorder, unspecified
F15.980 Other stimulant use, unspecified with stimulant-induced anxiety disorder
F15.981 Other stimulant use, unspecified with stimulant-induced sexual dysfunction
F15.988 Other stimulant use, unspecified with other stimulant-induced disorder
F15.99 Other stimulant use, unspecified with unspecified stimulant-induced disorder
F16.10 Hallucinogen abuse, uncomplicated
F16.120 Hallucinogen abuse with intoxication, uncomplicated
F16.121 Hallucinogen abuse with intoxication with delirium
F16.122 Hallucinogen abuse with intoxication with perceptual disturbance
F16.129 Hallucinogen abuse with intoxication, unspecified
F16.14 Hallucinogen abuse with hallucinogen-induced mood disorder
F16.150 Hallucinogen abuse with hallucinogen-induced psychotic disorder with delusions
F16.151 Hallucinogen abuse with hallucinogen-induced psychotic disorder with hallucinations
F16.159 Hallucinogen abuse with hallucinogen-induced psychotic disorder, unspecified
F16.180 Hallucinogen abuse with hallucinogen-induced anxiety disorder
F16.183 Hallucinogen abuse with hallucinogen persisting perception disorder (flashbacks)
F16.188 Hallucinogen abuse with other hallucinogen-induced disorder
F16.19 Hallucinogen abuse with unspecified hallucinogen-induced disorder
F16.20 Hallucinogen dependence, uncomplicated
F16.21 Hallucinogen dependence, in remission
F16.259 Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified
F16.280 Hallucinogen dependence with hallucinogen-induced anxiety disorder
F16.283 Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks)
F16.288 Hallucinogen dependence with other hallucinogen-induced disorder
F16.90 Hallucinogen use, unspecified, uncomplicated
F16.920 Hallucinogen use, unspecified with intoxication, uncomplicated
F16.921 Hallucinogen use, unspecified with intoxication with delirium
F16.929 Hallucinogen use, unspecified with intoxication, unspecified
F16.94 Hallucinogen use, unspecified with hallucinogen-induced mood disorder
F16.950 Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with delusions
F16.951 Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder with hallucinations
F16.959 Hallucinogen use, unspecified with hallucinogen-induced psychotic disorder, unspecified
F16.980 Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder
F16.983 Hallucinogen use, unspecified with hallucinogen persisting perception disorder (flashbacks)
F16.988 Hallucinogen use, unspecified with other hallucinogen-induced disorder
F16.99 Hallucinogen use, unspecified with unspecified hallucinogen-induced disorder
F17.203 Nicotine dependence unspecified, with withdrawal
F17.208 Nicotine dependence, unspecified, with other nicotine-induced disorders
F17.209 Nicotine dependence, unspecified, with unspecified nicotine-induced disorders
F17.213 Nicotine dependence, cigarettes, with withdrawal
F17.218 Nicotine dependence, cigarettes, with other nicotine-induced disorders
F17.219 Nicotine dependence, cigarettes, with unspecified nicotine-induced disorders
F17.223 Nicotine dependence, chewing tobacco, with withdrawal
F17.228 Nicotine dependence, chewing tobacco, with other nicotine-induced disorders
F17.229 Nicotine dependence, chewing tobacco, with unspecified nicotine-induced disorders
F17.293 Nicotine dependence, other tobacco product, with withdrawal
F17.298 Nicotine dependence, other tobacco product, with other nicotine-induced disorders
F17.299 Nicotine dependence, other tobacco product, with unspecified nicotine-induced disorders
F18.120 Inhalant abuse with intoxication, uncomplicated
F18.121 Inhalant abuse with intoxication delirium
F18.129 Inhalant abuse with intoxication, unspecified
F18.14 Inhalant abuse with inhalant-induced mood disorder
F18.150 Inhalant abuse with inhalant-induced psychotic disorder with delusions
F18.151 Inhalant abuse with inhalant-induced psychotic disorder with hallucinations
F18.159 Inhalant abuse with inhalant-induced psychotic disorder, unspecified
F18.17 Inhalant abuse with inhalant-induced dementia
F18.180 Inhalant abuse with inhalant-induced anxiety disorder
F18.188 Inhalant abuse with other inhalant-induced disorder
F18.19 Inhalant abuse with unspecified inhalant-induced disorder
F18.20 Inhalant dependence, uncomplicated
F18.21 Inhalant dependence, in remission
F18.259 Inhalant dependence with inhalant-induced psychotic disorder, unspecified
F18.280 Inhalant dependence with inhalant-induced anxiety disorder
F18.288 Inhalant dependence with other inhalant-induced disorder
F18.920 Inhalant use, unspecified with intoxication, uncomplicated
F18.921 Inhalant use, unspecified with intoxication with delirium
F18.929 Inhalant use, unspecified with intoxication, unspecified
F18.94 Inhalant use, unspecified with inhalant-induced mood disorder
F18.950 Inhalant use, unspecified with inhalant-induced psychotic disorder with delusions
F18.951 Inhalant use, unspecified with inhalant-induced psychotic disorder with hallucinations
F18.959 Inhalant use, unspecified with inhalant-induced psychotic disorder, unspecified
F18.97 Inhalant use, unspecified with inhalant-induced persisting dementia
F18.980 Inhalant use, unspecified with inhalant-induced anxiety disorder
F18.988 Inhalant use, unspecified with other inhalant-induced disorder
F18.99 Inhalant use, unspecified with unspecified inhalant-induced disorder
F19.10* Other psychoactive substance abuse, uncomplicated
F19.120* Other psychoactive substance abuse with intoxication, uncomplicated
F19.121 Other psychoactive substance abuse with intoxication delirium
F19.122 Other psychoactive substance abuse with intoxication with perceptual disturbances
F19.129 Other psychoactive substance abuse with intoxication, unspecified
F19.14 Other psychoactive substance abuse with psychoactive substance-induced mood disorder
F19.150 Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with delusions
F19.151 Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with hallucinations
F19.159 Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder, unspecified
F19.16 Other psychoactive substance abuse with psychoactive substance-induced persisting amnestic disorder
F19.17 Other psychoactive substance abuse with psychoactive substance-induced persisting dementia
F19.180 Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder
F19.181 Other psychoactive substance abuse with psychoactive substance-induced sexual dysfunction
F19.188 Other psychoactive substance abuse with other psychoactive substance-induced disorder
F19.19 Other psychoactive substance abuse with unspecified psychoactive substance-induced disorder
F19.20* Other psychoactive substance dependence, uncomplicated
F19.21* Other psychoactive substance dependence, in remission
F19.222 Other psychoactive substance dependence with intoxication with perceptual disturbance
F19.259 Other psychoactive substance dependence with psychoactive substance-induced psychotic disorder, unspecified
F19.280 Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder
F19.281 Other psychoactive substance dependence with psychoactive substance-induced sexual dysfunction
F19.288 Other psychoactive substance dependence with other psychoactive substance-induced disorder
F19.90* Other psychoactive substance use, unspecified, uncomplicated
F19.920 Other psychoactive substance use, unspecified with intoxication, uncomplicated
F19.921 Other psychoactive substance use, unspecified with intoxication with delirium
F19.922 Other psychoactive substance use, unspecified with intoxication with perceptual disturbance
F19.929 Other psychoactive substance use, unspecified with intoxication, unspecified
F19.930 Other psychoactive substance use, unspecified with withdrawal, uncomplicated
F19.931 Other psychoactive substance use, unspecified with withdrawal delirium
F19.932 Other psychoactive substance use, unspecified with withdrawal with perceptual disturbance
F19.939 Other psychoactive substance use, unspecified with withdrawal, unspecified
F19.94 Other psychoactive substance use, unspecified with psychoactive substance-induced mood disorder
F19.950 Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with delusions
F19.951 Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with hallucinations
F19.959 Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder, unspecified
F19.96 Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder
F19.97 Other psychoactive substance use, unspecified with psychoactive substance-induced persisting dementia
F19.980 Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder
F19.981 Other psychoactive substance use, unspecified with psychoactive substance-induced sexual dysfunction
F19.988 Other psychoactive substance use, unspecified with other psychoactive substance-induced disorder
F19.99 Other psychoactive substance use, unspecified with unspecified psychoactive substance-induced disorder
F20.0 Paranoid schizophrenia
F20.1 Disorganized schizophrenia
F20.2 Catatonic schizophrenia
F20.3 Undifferentiated schizophrenia
F20.5 Residual schizophrenia
F20.81 Schizophreniform disorder
F20.89 Other schizophrenia
F20.9 Schizophrenia, unspecified
F22 Delusional disorders
F23 Brief psychotic disorder
F24 Shared psychotic disorder
F25.0 Schizoaffective disorder, bipolar type
F25.1 Schizoaffective disorder, depressive type
F25.8 Other schizoaffective disorders
F25.9 Schizoaffective disorder, unspecified
F28 Other psychotic disorder not due to a substance or known physiological condition
F29 Unspecified psychosis not due to a substance or known physiological condition
F30.10 Manic episode without psychotic symptoms, unspecified
F30.11 Manic episode without psychotic symptoms, mild
F30.12 Manic episode without psychotic symptoms, moderate
F30.13 Manic episode, severe, without psychotic symptoms
F30.2 Manic episode, severe with psychotic symptoms
F30.3 Manic episode in partial remission
F30.8 Other manic episodes
F30.9 Manic episode, unspecified
F31.0 Bipolar disorder, current episode hypomanic
F31.10 Bipolar disorder, current episode manic without psychotic features, unspecified
F31.11 Bipolar disorder, current episode manic without psychotic features, mild
F31.12 Bipolar disorder, current episode manic without psychotic features, moderate
F31.13 Bipolar disorder, current episode manic without psychotic features, severe
F31.2 Bipolar disorder, current episode manic severe with psychotic features
F31.30 Bipolar disorder, current episode depressed, mild or moderate severity, unspecified
F31.31 Bipolar disorder, current episode depressed, mild
F31.32 Bipolar disorder, current episode depressed, moderate
F31.4 Bipolar disorder, current episode depressed, severe, without psychotic features
F31.5 Bipolar disorder, current episode depressed, severe, with psychotic features
F31.60 Bipolar disorder, current episode mixed, unspecified
F31.61 Bipolar disorder, current episode mixed, mild
F31.62 Bipolar disorder, current episode mixed, moderate
F31.63 Bipolar disorder, current episode mixed, severe, without psychotic features
F31.64 Bipolar disorder, current episode mixed, severe, with psychotic features
F31.70 Bipolar disorder, currently in remission, most recent episode unspecified
F31.71 Bipolar disorder, in partial remission, most recent episode hypomanic
F31.72 Bipolar disorder, in full remission, most recent episode hypomanic
F31.73 Bipolar disorder, in partial remission, most recent episode manic
F31.75 Bipolar disorder, in partial remission, most recent episode depressed
F31.77 Bipolar disorder, in partial remission, most recent episode mixed
F31.81 Bipolar II disorder
F31.89 Other bipolar disorder
F31.9 Bipolar disorder, unspecified
F32.0 Major depressive disorder, single episode, mild
F32.1 Major depressive disorder, single episode, moderate
F32.2 Major depressive disorder, single episode, severe without psychotic features
F32.3 Major depressive disorder, single episode, severe with psychotic features
F32.4 Major depressive disorder, single episode, in partial remission
F32.89 Other specified depressive episodes
F32.9 Major depressive disorder, single episode, unspecified
F33.0 Major depressive disorder, recurrent, mild
F33.1 Major depressive disorder, recurrent, moderate
F33.2 Major depressive disorder, recurrent severe without psychotic features
F33.3 Major depressive disorder, recurrent, severe with psychotic symptoms
F33.40 Major depressive disorder, recurrent, in remission, unspecified
F33.41 Major depressive disorder, recurrent, in partial remission
F33.8 Other recurrent depressive disorders
F33.9 Major depressive disorder, recurrent, unspecified
F34.81 Disruptive mood dysregulation disorder
F34.89 Other specified persistent mood disorders
F34.9 Persistent mood [affective] disorder, unspecified
F39 Unspecified mood [affective] disorder
F40.00 Agoraphobia, unspecified
F40.01 Agoraphobia with panic disorder
F40.02 Agoraphobia without panic disorder
F40.10 Social phobia, unspecified
F40.11 Social phobia, generalized
F40.210* Arachnophobia
F40.218* Other animal type phobia
F40.220* Fear of thunderstorms
F40.228* Other natural environment type phobia
F40.230* Fear of blood
F40.231* Fear of injections and transfusions
F40.232* Fear of other medical care
F40.233* Fear of injury
F40.240* Claustrophobia
F40.241* Acrophobia
F40.242* Fear of bridges
F40.243* Fear of flying
F40.248* Other situational type phobia
F40.290* Androphobia
F40.291* Gynephobia
F40.298* Other specified phobia
F40.8* Other phobic anxiety disorders
F40.9 Phobic anxiety disorder, unspecified
F41.0 Panic disorder [episodic paroxysmal anxiety]
F41.1 Generalized anxiety disorder
F41.3 Other mixed anxiety disorders
F41.8 Other specified anxiety disorders
F41.9 Anxiety disorder, unspecified
F44.89 Other dissociative and conversion disorders
F44.9* Dissociative and conversion disorder, unspecified
F53.1 Puerperal psychosis
F72 Severe intellectual disabilities
F73 Profound intellectual disabilities
F78.A9 Other genetic related intellectual disability
F79 Unspecified intellectual disabilities
F84.0 Autistic disorder
F84.3 Other childhood disintegrative disorder
F84.5* Asperger's syndrome
F84.8* Other pervasive developmental disorders
F91.9 Conduct disorder, unspecified
G06.0 Intracranial abscess and granuloma
G12.21 Amyotrophic lateral sclerosis
G12.25 Progressive spinal muscle atrophy
G20.A1* Parkinson's disease without dyskinesia, without mention of fluctuations
G20.A2* Parkinson's disease without dyskinesia, with fluctuations
G20.B1* Parkinson's disease with dyskinesia, without mention of fluctuations
G20.B2* Parkinson's disease with dyskinesia, with fluctuations
G21.11* Neuroleptic induced parkinsonism
G21.19* Other drug induced secondary parkinsonism
G21.2* Secondary parkinsonism due to other external agents
G21.3* Postencephalitic parkinsonism
G21.4* Vascular parkinsonism
G21.8* Other secondary parkinsonism
G21.9* Secondary parkinsonism, unspecified
G30.0 Alzheimer's disease with early onset
G30.1 Alzheimer's disease with late onset
G30.8 Other Alzheimer's disease
G30.9 Alzheimer's disease, unspecified
G31.85 Corticobasal degeneration
G35* Multiple sclerosis
G40.001 Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, with status epilepticus
G40.009 Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, not intractable, without status epilepticus
G40.011 Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, with status epilepticus
G40.019 Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset, intractable, without status epilepticus
G40.101 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, with status epilepticus
G40.109 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, not intractable, without status epilepticus
G40.111 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, with status epilepticus
G40.119 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures, intractable, without status epilepticus
G40.201 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, with status epilepticus
G40.209 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus
G40.211 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, with status epilepticus
G40.219 Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, intractable, without status epilepticus
G40.301 Generalized idiopathic epilepsy and epileptic syndromes, not intractable, with status epilepticus
G40.309 Generalized idiopathic epilepsy and epileptic syndromes, not intractable, without status epilepticus
G40.311 Generalized idiopathic epilepsy and epileptic syndromes, intractable, with status epilepticus
G40.319 Generalized idiopathic epilepsy and epileptic syndromes, intractable, without status epilepticus
G40.A01 Absence epileptic syndrome, not intractable, with status epilepticus
G40.A09 Absence epileptic syndrome, not intractable, without status epilepticus
G40.A11 Absence epileptic syndrome, intractable, with status epilepticus
G40.A19 Absence epileptic syndrome, intractable, without status epilepticus
G40.B01 Juvenile myoclonic epilepsy, not intractable, with status epilepticus
G40.B09 Juvenile myoclonic epilepsy, not intractable, without status epilepticus
G40.B11 Juvenile myoclonic epilepsy, intractable, with status epilepticus
G40.B19 Juvenile myoclonic epilepsy, intractable, without status epilepticus
G40.401 Other generalized epilepsy and epileptic syndromes, not intractable, with status epilepticus
G40.409 Other generalized epilepsy and epileptic syndromes, not intractable, without status epilepticus
G40.411 Other generalized epilepsy and epileptic syndromes, intractable, with status epilepticus
G40.419 Other generalized epilepsy and epileptic syndromes, intractable, without status epilepticus
G40.501 Epileptic seizures related to external causes, not intractable, with status epilepticus
G40.509 Epileptic seizures related to external causes, not intractable, without status epilepticus
G40.801 Other epilepsy, not intractable, with status epilepticus
G40.802 Other epilepsy, not intractable, without status epilepticus
G40.803 Other epilepsy, intractable, with status epilepticus
G40.804 Other epilepsy, intractable, without status epilepticus
G40.811 Lennox-Gastaut syndrome, not intractable, with status epilepticus
G40.812 Lennox-Gastaut syndrome, not intractable, without status epilepticus
G40.813 Lennox-Gastaut syndrome, intractable, with status epilepticus
G40.814 Lennox-Gastaut syndrome, intractable, without status epilepticus
G40.821 Epileptic spasms, not intractable, with status epilepticus
G40.822 Epileptic spasms, not intractable, without status epilepticus
G40.823 Epileptic spasms, intractable, with status epilepticus
G40.824 Epileptic spasms, intractable, without status epilepticus
G40.89 Other seizures
G40.901* Epilepsy, unspecified, not intractable, with status epilepticus
G40.909* Epilepsy, unspecified, not intractable, without status epilepticus
G40.911* Epilepsy, unspecified, intractable, with status epilepticus
G40.919* Epilepsy, unspecified, intractable, without status epilepticus
G45.0 Vertebro-basilar artery syndrome
G45.1 Carotid artery syndrome (hemispheric)
G45.2 Multiple and bilateral precerebral artery syndromes
G45.4* Transient global amnesia
G45.8 Other transient cerebral ischemic attacks and related syndromes
G45.9 Transient cerebral ischemic attack, unspecified
G46.0 Middle cerebral artery syndrome
G46.1 Anterior cerebral artery syndrome
G46.2 Posterior cerebral artery syndrome
G46.3* Brain stem stroke syndrome
G46.4* Cerebellar stroke syndrome
G46.5* Pure motor lacunar syndrome
G46.6* Pure sensory lacunar syndrome
G46.7* Other lacunar syndromes
G46.8* Other vascular syndromes of brain in cerebrovascular diseases
G47.33 Obstructive sleep apnea (adult) (pediatric)
G70.00 Myasthenia gravis without (acute) exacerbation
G70.80 Lambert-Eaton syndrome, unspecified
G70.81 Lambert-Eaton syndrome in disease classified elsewhere
G73.1 Lambert-Eaton syndrome in neoplastic disease
G80.9* Cerebral palsy, unspecified
G97.81 Other intraoperative complications of nervous system
H35.20 Other non-diabetic proliferative retinopathy, unspecified eye
H35.21 Other non-diabetic proliferative retinopathy, right eye
H35.22 Other non-diabetic proliferative retinopathy, left eye
H35.23 Other non-diabetic proliferative retinopathy, bilateral
H35.3210 Exudative age-related macular degeneration, right eye, stage unspecified
H35.3211 Exudative age-related macular degeneration, right eye, with active choroidal neovascularization
H35.3212 Exudative age-related macular degeneration, right eye, with inactive choroidal neovascularization
H35.3213 Exudative age-related macular degeneration, right eye, with inactive scar
H35.3220 Exudative age-related macular degeneration, left eye, stage unspecified
H35.3221 Exudative age-related macular degeneration, left eye, with active choroidal neovascularization
H35.3222 Exudative age-related macular degeneration, left eye, with inactive choroidal neovascularization
H35.3223 Exudative age-related macular degeneration, left eye, with inactive scar
H35.3230 Exudative age-related macular degeneration, bilateral, stage unspecified
H35.3231 Exudative age-related macular degeneration, bilateral, with active choroidal neovascularization
H35.3232 Exudative age-related macular degeneration, bilateral, with inactive choroidal neovascularization
H35.3233 Exudative age-related macular degeneration, bilateral, with inactive scar
H35.341 Macular cyst, hole, or pseudohole, right eye
H35.342 Macular cyst, hole, or pseudohole, left eye
H35.343 Macular cyst, hole, or pseudohole, bilateral
H35.349 Macular cyst, hole, or pseudohole, unspecified eye
H35.371 Puckering of macula, right eye
H35.372 Puckering of macula, left eye
H35.373 Puckering of macula, bilateral
H35.379 Puckering of macula, unspecified eye
I01.0* Acute rheumatic pericarditis
I01.1* Acute rheumatic endocarditis
I01.2* Acute rheumatic myocarditis
I05.0 Rheumatic mitral stenosis
I05.1 Rheumatic mitral insufficiency
I05.2 Rheumatic mitral stenosis with insufficiency
I05.8 Other rheumatic mitral valve diseases
I05.9 Rheumatic mitral valve disease, unspecified
I08.1* Rheumatic disorders of both mitral and tricuspid valves
I08.2* Rheumatic disorders of both aortic and tricuspid valves
I08.3* Combined rheumatic disorders of mitral, aortic and tricuspid valves
I08.8* Other rheumatic multiple valve diseases
I08.9* Rheumatic multiple valve disease, unspecified
I09.1* Rheumatic diseases of endocardium, valve unspecified
I10* Essential (primary) hypertension
I11.0* Hypertensive heart disease with heart failure
I11.9* Hypertensive heart disease without heart failure
I12.0 Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease
I12.9 Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
I13.0 Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
I13.10 Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease
I13.11 Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease
I13.2 Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease
I15.0 Renovascular hypertension
I15.1 Hypertension secondary to other renal disorders
I20.0 Unstable angina
I20.1 Angina pectoris with documented spasm
I20.2 Refractory angina pectoris
I20.81 Angina pectoris with coronary microvascular dysfunction
I20.89 Other forms of angina pectoris
I20.9 Angina pectoris, unspecified
I21.01 ST elevation (STEMI) myocardial infarction involving left main coronary artery
I21.02 ST elevation (STEMI) myocardial infarction involving left anterior descending coronary artery
I21.09 ST elevation (STEMI) myocardial infarction involving other coronary artery of anterior wall
I21.11 ST elevation (STEMI) myocardial infarction involving right coronary artery
I21.19 ST elevation (STEMI) myocardial infarction involving other coronary artery of inferior wall
I21.21 ST elevation (STEMI) myocardial infarction involving left circumflex coronary artery
I21.29 ST elevation (STEMI) myocardial infarction involving other sites
I21.3 ST elevation (STEMI) myocardial infarction of unspecified site
I21.4 Non-ST elevation (NSTEMI) myocardial infarction
I21.9 Acute myocardial infarction, unspecified
I21.B Myocardial infarction with coronary microvascular dysfunction
I22.0 Subsequent ST elevation (STEMI) myocardial infarction of anterior wall
I22.1 Subsequent ST elevation (STEMI) myocardial infarction of inferior wall
I22.2 Subsequent non-ST elevation (NSTEMI) myocardial infarction
I22.8 Subsequent ST elevation (STEMI) myocardial infarction of other sites
I22.9 Subsequent ST elevation (STEMI) myocardial infarction of unspecified site
I24.0 Acute coronary thrombosis not resulting in myocardial infarction
I24.1 Dressler's syndrome
I24.81* Acute coronary microvascular dysfunction
I24.89* Other forms of acute ischemic heart disease
I24.9* Acute ischemic heart disease, unspecified
I25.10 Atherosclerotic heart disease of native coronary artery without angina pectoris
I25.110 Atherosclerotic heart disease of native coronary artery with unstable angina pectoris
I25.111 Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm
I25.112 Atherosclerotic heart disease of native coronary artery with refractory angina pectoris
I25.118 Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris
I25.119 Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris
I25.2* Old myocardial infarction
I25.3 Aneurysm of heart
I25.41 Coronary artery aneurysm
I25.42 Coronary artery dissection
I25.5* Ischemic cardiomyopathy
I25.6* Silent myocardial ischemia
I25.700 Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris
I25.701 Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm
I25.702 Atherosclerosis of coronary artery bypass graft(s), unspecified, with refractory angina pectoris
I25.708 Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris
I25.710 Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris
I25.711 Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm
I25.712 Atherosclerosis of autologous vein coronary artery bypass graft(s) with refractory angina pectoris
I25.718 Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris
I25.719 Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris
I25.720 Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris
I25.721 Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm
I25.722 Atherosclerosis of autologous artery coronary artery bypass graft(s) with refractory angina pectoris
I25.728 Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris
I25.729 Atherosclerosis of autologous artery coronary artery bypass graft(s) with unspecified angina pectoris
I25.730 Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris
I25.731 Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm
I25.732 Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with refractory angina pectoris
I25.738 Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris
I25.739 Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris
I25.750 Atherosclerosis of native coronary artery of transplanted heart with unstable angina
I25.751 Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm
I25.752 Atherosclerosis of native coronary artery of transplanted heart with refractory angina pectoris
I25.758 Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris
I25.759 Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris
I25.760 Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina
I25.761 Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm
I25.762 Atherosclerosis of bypass graft of coronary artery of transplanted heart with refractory angina pectoris
I25.768 Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris
I25.769 Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris
I25.790 Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris
I25.791 Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm
I25.792 Atherosclerosis of other coronary artery bypass graft(s) with refractory angina pectoris
I25.798 Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris
I25.799 Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris
I25.810 Atherosclerosis of coronary artery bypass graft(s) without angina pectoris
I25.811 Atherosclerosis of native coronary artery of transplanted heart without angina pectoris
I25.812 Atherosclerosis of bypass graft of coronary artery of transplanted heart without angina pectoris
I25.82 Chronic total occlusion of coronary artery
I25.83 Coronary atherosclerosis due to lipid rich plaque
I25.84 Coronary atherosclerosis due to calcified coronary lesion
I25.85* Chronic coronary microvascular dysfunction
I25.89* Other forms of chronic ischemic heart disease
I25.9* Chronic ischemic heart disease, unspecified
I26.03 Cement embolism of pulmonary artery with acute cor pulmonale
I26.04 Fat embolism of pulmonary artery with acute cor pulmonale
I26.09 Other pulmonary embolism with acute cor pulmonale
I27.0 Primary pulmonary hypertension
I27.81* Cor pulmonale (chronic)
I27.82 Chronic pulmonary embolism
I27.9* Pulmonary heart disease, unspecified
I30.0 Acute nonspecific idiopathic pericarditis
I30.1 Infective pericarditis
I30.8 Other forms of acute pericarditis
I30.9 Acute pericarditis, unspecified
I31.0 Chronic adhesive pericarditis
I31.1 Chronic constrictive pericarditis
I31.2 Hemopericardium, not elsewhere classified
I31.31 Malignant pericardial effusion in diseases classified elsewhere
I31.39 Other pericardial effusion (noninflammatory)
I31.8 Other specified diseases of pericardium
I31.9 Disease of pericardium, unspecified
I32 Pericarditis in diseases classified elsewhere
I33.0 Acute and subacute infective endocarditis
I33.9 Acute and subacute endocarditis, unspecified
I34.0 Nonrheumatic mitral (valve) insufficiency
I34.1 Nonrheumatic mitral (valve) prolapse
I34.2 Nonrheumatic mitral (valve) stenosis
I34.81 Nonrheumatic mitral (valve) annulus calcification
I34.89 Other nonrheumatic mitral valve disorders
I34.9 Nonrheumatic mitral valve disorder, unspecified
I35.0 Nonrheumatic aortic (valve) stenosis
I35.1 Nonrheumatic aortic (valve) insufficiency
I35.2 Nonrheumatic aortic (valve) stenosis with insufficiency
I35.8 Other nonrheumatic aortic valve disorders
I35.9 Nonrheumatic aortic valve disorder, unspecified
I36.0 Nonrheumatic tricuspid (valve) stenosis
I36.1 Nonrheumatic tricuspid (valve) insufficiency
I36.2 Nonrheumatic tricuspid (valve) stenosis with insufficiency
I36.8 Other nonrheumatic tricuspid valve disorders
I36.9 Nonrheumatic tricuspid valve disorder, unspecified
I37.0 Nonrheumatic pulmonary valve stenosis
I37.1 Nonrheumatic pulmonary valve insufficiency
I37.2 Nonrheumatic pulmonary valve stenosis with insufficiency
I37.8 Other nonrheumatic pulmonary valve disorders
I37.9 Nonrheumatic pulmonary valve disorder, unspecified
I38* Endocarditis, valve unspecified
I39 Endocarditis and heart valve disorders in diseases classified elsewhere
I40.0 Infective myocarditis
I40.1 Isolated myocarditis
I40.8 Other acute myocarditis
I40.9 Acute myocarditis, unspecified
I41 Myocarditis in diseases classified elsewhere
I42.0 Dilated cardiomyopathy
I42.1 Obstructive hypertrophic cardiomyopathy
I42.2 Other hypertrophic cardiomyopathy
I42.3 Endomyocardial (eosinophilic) disease
I42.4 Endocardial fibroelastosis
I42.5 Other restrictive cardiomyopathy
I42.6 Alcoholic cardiomyopathy
I42.7* Cardiomyopathy due to drug and external agent
I42.8 Other cardiomyopathies
I42.9* Cardiomyopathy, unspecified
I43* Cardiomyopathy in diseases classified elsewhere
I44.0 Atrioventricular block, first degree
I44.1 Atrioventricular block, second degree
I44.2 Atrioventricular block, complete
I44.30 Unspecified atrioventricular block
I44.39 Other atrioventricular block
I44.4 Left anterior fascicular block
I44.5 Left posterior fascicular block
I44.60 Unspecified fascicular block
I44.69 Other fascicular block
I44.7 Left bundle-branch block, unspecified
I45.0 Right fascicular block
I45.10 Unspecified right bundle-branch block
I45.19 Other right bundle-branch block
I45.2 Bifascicular block
I45.3 Trifascicular block
I45.4 Nonspecific intraventricular block
I45.5 Other specified heart block
I45.6 Pre-excitation syndrome
I45.81 Long QT syndrome
I45.89 Other specified conduction disorders
I45.9* Conduction disorder, unspecified
I46.2 Cardiac arrest due to underlying cardiac condition
I46.8 Cardiac arrest due to other underlying condition
I46.9 Cardiac arrest, cause unspecified
I47.0 Re-entry ventricular arrhythmia
I47.11 Inappropriate sinus tachycardia, so stated
I47.19 Other supraventricular tachycardia
I47.21 Torsades de pointes
I47.29 Other ventricular tachycardia
I47.9 Paroxysmal tachycardia, unspecified
I48.0 Paroxysmal atrial fibrillation
I48.11 Longstanding persistent atrial fibrillation
I48.19 Other persistent atrial fibrillation
I48.20 Chronic atrial fibrillation, unspecified
I48.21 Permanent atrial fibrillation
I48.3 Typical atrial flutter
I48.4 Atypical atrial flutter
I48.91 Unspecified atrial fibrillation
I48.92 Unspecified atrial flutter
I49.01 Ventricular fibrillation
I49.02 Ventricular flutter
I49.1 Atrial premature depolarization
I49.2 Junctional premature depolarization
I49.3 Ventricular premature depolarization
I49.40 Unspecified premature depolarization
I49.49 Other premature depolarization
I49.5 Sick sinus syndrome
I49.8* Other specified cardiac arrhythmias
I50.1 Left ventricular failure, unspecified
I50.20 Unspecified systolic (congestive) heart failure
I50.21 Acute systolic (congestive) heart failure
I50.22 Chronic systolic (congestive) heart failure
I50.23 Acute on chronic systolic (congestive) heart failure
I50.30 Unspecified diastolic (congestive) heart failure
I50.31 Acute diastolic (congestive) heart failure
I50.32 Chronic diastolic (congestive) heart failure
I50.33 Acute on chronic diastolic (congestive) heart failure
I50.40 Unspecified combined systolic (congestive) and diastolic (congestive) heart failure
I50.41 Acute combined systolic (congestive) and diastolic (congestive) heart failure
I50.42 Chronic combined systolic (congestive) and diastolic (congestive) heart failure
I50.43 Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure
I50.810* Right heart failure, unspecified
I50.811* Acute right heart failure
I50.812* Chronic right heart failure
I50.813* Acute on chronic right heart failure
I50.814* Right heart failure due to left heart failure
I50.82* Biventricular heart failure
I50.83* High output heart failure
I50.84* End stage heart failure
I50.89* Other heart failure
I50.9* Heart failure, unspecified
I60.00 Nontraumatic subarachnoid hemorrhage from unspecified carotid siphon and bifurcation
I60.01 Nontraumatic subarachnoid hemorrhage from right carotid siphon and bifurcation
I60.02 Nontraumatic subarachnoid hemorrhage from left carotid siphon and bifurcation
I60.10 Nontraumatic subarachnoid hemorrhage from unspecified middle cerebral artery
I60.11 Nontraumatic subarachnoid hemorrhage from right middle cerebral artery
I60.12 Nontraumatic subarachnoid hemorrhage from left middle cerebral artery
I60.2 Nontraumatic subarachnoid hemorrhage from anterior communicating artery
I60.30 Nontraumatic subarachnoid hemorrhage from unspecified posterior communicating artery
I60.31 Nontraumatic subarachnoid hemorrhage from right posterior communicating artery
I60.32 Nontraumatic subarachnoid hemorrhage from left posterior communicating artery
I60.4 Nontraumatic subarachnoid hemorrhage from basilar artery
I60.50 Nontraumatic subarachnoid hemorrhage from unspecified vertebral artery
I60.51 Nontraumatic subarachnoid hemorrhage from right vertebral artery
I60.52 Nontraumatic subarachnoid hemorrhage from left vertebral artery
I60.6 Nontraumatic subarachnoid hemorrhage from other intracranial arteries
I60.7 Nontraumatic subarachnoid hemorrhage from unspecified intracranial artery
I60.8 Other nontraumatic subarachnoid hemorrhage
I60.9 Nontraumatic subarachnoid hemorrhage, unspecified
I61.0 Nontraumatic intracerebral hemorrhage in hemisphere, subcortical
I61.1 Nontraumatic intracerebral hemorrhage in hemisphere, cortical
I61.2 Nontraumatic intracerebral hemorrhage in hemisphere, unspecified
I61.3 Nontraumatic intracerebral hemorrhage in brain stem
I61.4 Nontraumatic intracerebral hemorrhage in cerebellum
I61.5 Nontraumatic intracerebral hemorrhage, intraventricular
I61.6 Nontraumatic intracerebral hemorrhage, multiple localized
I61.8 Other nontraumatic intracerebral hemorrhage
I61.9 Nontraumatic intracerebral hemorrhage, unspecified
I62.00 Nontraumatic subdural hemorrhage, unspecified
I62.01 Nontraumatic acute subdural hemorrhage
I62.02 Nontraumatic subacute subdural hemorrhage
I62.03 Nontraumatic chronic subdural hemorrhage
I62.1 Nontraumatic extradural hemorrhage
I63.00 Cerebral infarction due to thrombosis of unspecified precerebral artery
I63.011 Cerebral infarction due to thrombosis of right vertebral artery
I63.012 Cerebral infarction due to thrombosis of left vertebral artery
I63.013 Cerebral infarction due to thrombosis of bilateral vertebral arteries
I63.019 Cerebral infarction due to thrombosis of unspecified vertebral artery
I63.02 Cerebral infarction due to thrombosis of basilar artery
I63.031 Cerebral infarction due to thrombosis of right carotid artery
I63.032 Cerebral infarction due to thrombosis of left carotid artery
I63.033 Cerebral infarction due to thrombosis of bilateral carotid arteries
I63.039 Cerebral infarction due to thrombosis of unspecified carotid artery
I63.09 Cerebral infarction due to thrombosis of other precerebral artery
I63.10 Cerebral infarction due to embolism of unspecified precerebral artery
I63.111 Cerebral infarction due to embolism of right vertebral artery
I63.112 Cerebral infarction due to embolism of left vertebral artery
I63.113 Cerebral infarction due to embolism of bilateral vertebral arteries
I63.119 Cerebral infarction due to embolism of unspecified vertebral artery
I63.12 Cerebral infarction due to embolism of basilar artery
I63.131 Cerebral infarction due to embolism of right carotid artery
I63.132 Cerebral infarction due to embolism of left carotid artery
I63.133 Cerebral infarction due to embolism of bilateral carotid arteries
I63.139 Cerebral infarction due to embolism of unspecified carotid artery
I63.19 Cerebral infarction due to embolism of other precerebral artery
I63.20 Cerebral infarction due to unspecified occlusion or stenosis of unspecified precerebral arteries
I63.211 Cerebral infarction due to unspecified occlusion or stenosis of right vertebral artery
I63.212 Cerebral infarction due to unspecified occlusion or stenosis of left vertebral artery
I63.213 Cerebral infarction due to unspecified occlusion or stenosis of bilateral vertebral arteries
I63.219 Cerebral infarction due to unspecified occlusion or stenosis of unspecified vertebral artery
I63.22 Cerebral infarction due to unspecified occlusion or stenosis of basilar artery
I63.231 Cerebral infarction due to unspecified occlusion or stenosis of right carotid arteries
I63.232 Cerebral infarction due to unspecified occlusion or stenosis of left carotid arteries
I63.233 Cerebral infarction due to unspecified occlusion or stenosis of bilateral carotid arteries
I63.239 Cerebral infarction due to unspecified occlusion or stenosis of unspecified carotid artery
I63.29 Cerebral infarction due to unspecified occlusion or stenosis of other precerebral arteries
I63.30 Cerebral infarction due to thrombosis of unspecified cerebral artery
I63.311 Cerebral infarction due to thrombosis of right middle cerebral artery
I63.312 Cerebral infarction due to thrombosis of left middle cerebral artery
I63.313 Cerebral infarction due to thrombosis of bilateral middle cerebral arteries
I63.319 Cerebral infarction due to thrombosis of unspecified middle cerebral artery
I63.321 Cerebral infarction due to thrombosis of right anterior cerebral artery
I63.322 Cerebral infarction due to thrombosis of left anterior cerebral artery
I63.323 Cerebral infarction due to thrombosis of bilateral anterior cerebral arteries
I63.329 Cerebral infarction due to thrombosis of unspecified anterior cerebral artery
I63.331 Cerebral infarction due to thrombosis of right posterior cerebral artery
I63.332 Cerebral infarction due to thrombosis of left posterior cerebral artery
I63.333 Cerebral infarction due to thrombosis of bilateral posterior cerebral arteries
I63.339 Cerebral infarction due to thrombosis of unspecified posterior cerebral artery
I63.341 Cerebral infarction due to thrombosis of right cerebellar artery
I63.342 Cerebral infarction due to thrombosis of left cerebellar artery
I63.343 Cerebral infarction due to thrombosis of bilateral cerebellar arteries
I63.349 Cerebral infarction due to thrombosis of unspecified cerebellar artery
I63.39 Cerebral infarction due to thrombosis of other cerebral artery
I63.40 Cerebral infarction due to embolism of unspecified cerebral artery
I63.411 Cerebral infarction due to embolism of right middle cerebral artery
I63.412 Cerebral infarction due to embolism of left middle cerebral artery
I63.413 Cerebral infarction due to embolism of bilateral middle cerebral arteries
I63.419 Cerebral infarction due to embolism of unspecified middle cerebral artery
I63.421 Cerebral infarction due to embolism of right anterior cerebral artery
I63.422 Cerebral infarction due to embolism of left anterior cerebral artery
I63.423 Cerebral infarction due to embolism of bilateral anterior cerebral arteries
I63.429 Cerebral infarction due to embolism of unspecified anterior cerebral artery
I63.431 Cerebral infarction due to embolism of right posterior cerebral artery
I63.432 Cerebral infarction due to embolism of left posterior cerebral artery
I63.433 Cerebral infarction due to embolism of bilateral posterior cerebral arteries
I63.439 Cerebral infarction due to embolism of unspecified posterior cerebral artery
I63.441 Cerebral infarction due to embolism of right cerebellar artery
I63.442 Cerebral infarction due to embolism of left cerebellar artery
I63.443 Cerebral infarction due to embolism of bilateral cerebellar arteries
I63.449 Cerebral infarction due to embolism of unspecified cerebellar artery
I63.49 Cerebral infarction due to embolism of other cerebral artery
I63.50 Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebral artery
I63.511 Cerebral infarction due to unspecified occlusion or stenosis of right middle cerebral artery
I63.512 Cerebral infarction due to unspecified occlusion or stenosis of left middle cerebral artery
I63.513 Cerebral infarction due to unspecified occlusion or stenosis of bilateral middle cerebral arteries
I63.519 Cerebral infarction due to unspecified occlusion or stenosis of unspecified middle cerebral artery
I63.521 Cerebral infarction due to unspecified occlusion or stenosis of right anterior cerebral artery
I63.522 Cerebral infarction due to unspecified occlusion or stenosis of left anterior cerebral artery
I63.523 Cerebral infarction due to unspecified occlusion or stenosis of bilateral anterior cerebral arteries
I63.529 Cerebral infarction due to unspecified occlusion or stenosis of unspecified anterior cerebral artery
I63.531 Cerebral infarction due to unspecified occlusion or stenosis of right posterior cerebral artery
I63.532 Cerebral infarction due to unspecified occlusion or stenosis of left posterior cerebral artery
I63.533 Cerebral infarction due to unspecified occlusion or stenosis of bilateral posterior cerebral arteries
I63.539 Cerebral infarction due to unspecified occlusion or stenosis of unspecified posterior cerebral artery
I63.541 Cerebral infarction due to unspecified occlusion or stenosis of right cerebellar artery
I63.542 Cerebral infarction due to unspecified occlusion or stenosis of left cerebellar artery
I63.543 Cerebral infarction due to unspecified occlusion or stenosis of bilateral cerebellar arteries
I63.549 Cerebral infarction due to unspecified occlusion or stenosis of unspecified cerebellar artery
I63.59 Cerebral infarction due to unspecified occlusion or stenosis of other cerebral artery
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
I63.81 Other cerebral infarction due to occlusion or stenosis of small artery
I63.89 Other cerebral infarction
I63.9 Cerebral infarction, unspecified
I65.01 Occlusion and stenosis of right vertebral artery
I65.02 Occlusion and stenosis of left vertebral artery
I65.03 Occlusion and stenosis of bilateral vertebral arteries
I65.09 Occlusion and stenosis of unspecified vertebral artery
I65.1 Occlusion and stenosis of basilar artery
I65.21 Occlusion and stenosis of right carotid artery
I65.22 Occlusion and stenosis of left carotid artery
I65.23 Occlusion and stenosis of bilateral carotid arteries
I65.29 Occlusion and stenosis of unspecified carotid artery
I65.8 Occlusion and stenosis of other precerebral arteries
I65.9 Occlusion and stenosis of unspecified precerebral artery
I66.01 Occlusion and stenosis of right middle cerebral artery
I66.02 Occlusion and stenosis of left middle cerebral artery
I66.03 Occlusion and stenosis of bilateral middle cerebral arteries
I66.09 Occlusion and stenosis of unspecified middle cerebral artery
I66.11 Occlusion and stenosis of right anterior cerebral artery
I66.12 Occlusion and stenosis of left anterior cerebral artery
I66.13 Occlusion and stenosis of bilateral anterior cerebral arteries
I66.19 Occlusion and stenosis of unspecified anterior cerebral artery
I66.21 Occlusion and stenosis of right posterior cerebral artery
I66.22 Occlusion and stenosis of left posterior cerebral artery
I66.23 Occlusion and stenosis of bilateral posterior cerebral arteries
I66.29 Occlusion and stenosis of unspecified posterior cerebral artery
I66.3 Occlusion and stenosis of cerebellar arteries
I66.8 Occlusion and stenosis of other cerebral arteries
I66.9 Occlusion and stenosis of unspecified cerebral artery
I67.1* Cerebral aneurysm, nonruptured
I67.2* Cerebral atherosclerosis
I67.4* Hypertensive encephalopathy
I67.5* Moyamoya disease
I67.6* Nonpyogenic thrombosis of intracranial venous system
I67.7* Cerebral arteritis, not elsewhere classified
I67.81* Acute cerebrovascular insufficiency
I67.82* Cerebral ischemia
I67.841 Reversible cerebrovascular vasoconstriction syndrome
I67.848 Other cerebrovascular vasospasm and vasoconstriction
I67.89* Other cerebrovascular disease
I67.9* Cerebrovascular disease, unspecified
I68.0* Cerebral amyloid angiopathy
I68.2* Cerebral arteritis in other diseases classified elsewhere
I68.8* Other cerebrovascular disorders in diseases classified elsewhere
J40 Bronchitis, not specified as acute or chronic
J43.0 Unilateral pulmonary emphysema [MacLeod's syndrome]
J43.1 Panlobular emphysema
J43.2 Centrilobular emphysema
J43.8 Other emphysema
J43.9 Emphysema, unspecified
J44.9 Chronic obstructive pulmonary disease, unspecified
J45.50 Severe persistent asthma, uncomplicated
J60 Coalworker's pneumoconiosis
J61 Pneumoconiosis due to asbestos and other mineral fibers
J62.0 Pneumoconiosis due to talc dust
J62.8 Pneumoconiosis due to other dust containing silica
J63.0 Aluminosis (of lung)
J63.1 Bauxite fibrosis (of lung)
J63.2 Berylliosis
J63.3 Graphite fibrosis (of lung)
J63.4 Siderosis
J63.5 Stannosis
J63.6 Pneumoconiosis due to other specified inorganic dusts
J64 Unspecified pneumoconiosis
J65 Pneumoconiosis associated with tuberculosis
J66.0 Byssinosis
J66.1 Flax-dressers' disease
J66.2 Cannabinosis
J66.8 Airway disease due to other specific organic dusts
J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapors
J68.1 Pulmonary edema due to chemicals, gases, fumes and vapors
J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapors, not elsewhere classified
J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapors
J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapors
J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapors
J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapors
J70.0 Acute pulmonary manifestations due to radiation
J70.1 Chronic and other pulmonary manifestations due to radiation
J70.2 Acute drug-induced interstitial lung disorders
J70.3 Chronic drug-induced interstitial lung disorders
J70.4 Drug-induced interstitial lung disorders, unspecified
J70.5 Respiratory conditions due to smoke inhalation
J70.8 Respiratory conditions due to other specified external agents
J70.9 Respiratory conditions due to unspecified external agent
J80* Acute respiratory distress syndrome
J81.0 Acute pulmonary edema
J82.81 Chronic eosinophilic pneumonia
J82.82 Acute eosinophilic pneumonia
J82.83 Eosinophilic asthma
J82.89 Other pulmonary eosinophilia, not elsewhere classified
J85.0 Gangrene and necrosis of lung
J85.1 Abscess of lung with pneumonia
J85.2 Abscess of lung without pneumonia
J86.0 Pyothorax with fistula
J86.9 Pyothorax without fistula
J90 Pleural effusion, not elsewhere classified
J91.0 Malignant pleural effusion
J91.8 Pleural effusion in other conditions classified elsewhere
J92.0 Pleural plaque with presence of asbestos
J92.9 Pleural plaque without asbestos
J93.0 Spontaneous tension pneumothorax
J94.0 Chylous effusion
J94.1 Fibrothorax
J94.2 Hemothorax
J94.8 Other specified pleural conditions
J94.9 Pleural condition, unspecified
J95.1 Acute pulmonary insufficiency following thoracic surgery
J95.2 Acute pulmonary insufficiency following nonthoracic surgery
J95.3 Chronic pulmonary insufficiency following surgery
J95.811 Postprocedural pneumothorax
J95.812 Postprocedural air leak
J95.821 Acute postprocedural respiratory failure
J95.822 Acute and chronic postprocedural respiratory failure
J95.84 Transfusion-related acute lung injury (TRALI)
J96.00* Acute respiratory failure, unspecified whether with hypoxia or hypercapnia
J96.01* Acute respiratory failure with hypoxia
J96.02* Acute respiratory failure with hypercapnia
J96.20 Acute and chronic respiratory failure, unspecified whether with hypoxia or hypercapnia
J96.21 Acute and chronic respiratory failure with hypoxia
J96.22 Acute and chronic respiratory failure with hypercapnia
J96.90* Respiratory failure, unspecified, unspecified whether with hypoxia or hypercapnia
J96.91* Respiratory failure, unspecified with hypoxia
J96.92* Respiratory failure, unspecified with hypercapnia
J98.11 Atelectasis
J98.19 Other pulmonary collapse
J98.2 Interstitial emphysema
J98.3 Compensatory emphysema
K70.0 Alcoholic fatty liver
K70.10 Alcoholic hepatitis without ascites
K70.11 Alcoholic hepatitis with ascites
K70.2 Alcoholic fibrosis and sclerosis of liver
K70.30 Alcoholic cirrhosis of liver without ascites
K70.31 Alcoholic cirrhosis of liver with ascites
K70.40 Alcoholic hepatic failure without coma
K70.9 Alcoholic liver disease, unspecified
K72.00 Acute and subacute hepatic failure without coma
K72.10 Chronic hepatic failure without coma
K72.90 Hepatic failure, unspecified without coma
K72.91 Hepatic failure, unspecified with coma
K73.0 Chronic persistent hepatitis, not elsewhere classified
K73.1 Chronic lobular hepatitis, not elsewhere classified
K73.2 Chronic active hepatitis, not elsewhere classified
K73.8 Other chronic hepatitis, not elsewhere classified
K73.9 Chronic hepatitis, unspecified
K74.01 Hepatic fibrosis, early fibrosis
K74.02 Hepatic fibrosis, advanced fibrosis
K74.3 Primary biliary cirrhosis
K74.4 Secondary biliary cirrhosis
K74.5 Biliary cirrhosis, unspecified
K74.60 Unspecified cirrhosis of liver
K74.69 Other cirrhosis of liver
K75.0 Abscess of liver
K75.1 Phlebitis of portal vein
K75.4 Autoimmune hepatitis
K75.81 Nonalcoholic steatohepatitis (NASH)
K76.0 Fatty (change of) liver, not elsewhere classified
K76.2 Central hemorrhagic necrosis of liver
K76.6 Portal hypertension
K76.7 Hepatorenal syndrome
K76.89 Other specified diseases of liver
K85.00* Idiopathic acute pancreatitis without necrosis or infection
K85.01* Idiopathic acute pancreatitis with uninfected necrosis
K85.02* Idiopathic acute pancreatitis with infected necrosis
K85.10* Biliary acute pancreatitis without necrosis or infection
K85.11* Biliary acute pancreatitis with uninfected necrosis
K85.12* Biliary acute pancreatitis with infected necrosis
K85.20* Alcohol induced acute pancreatitis without necrosis or infection
K85.21* Alcohol induced acute pancreatitis with uninfected necrosis
K85.22* Alcohol induced acute pancreatitis with infected necrosis
K85.30* Drug induced acute pancreatitis without necrosis or infection
K85.31* Drug induced acute pancreatitis with uninfected necrosis
K85.32* Drug induced acute pancreatitis with infected necrosis
K85.80* Other acute pancreatitis without necrosis or infection
K85.81* Other acute pancreatitis with uninfected necrosis
K85.82* Other acute pancreatitis with infected necrosis
K85.90* Acute pancreatitis without necrosis or infection, unspecified
K85.91* Acute pancreatitis with uninfected necrosis, unspecified
K85.92* Acute pancreatitis with infected necrosis, unspecified
K86.0* Alcohol-induced chronic pancreatitis
K86.1* Other chronic pancreatitis
K92.2* Gastrointestinal hemorrhage, unspecified
N17.0 Acute kidney failure with tubular necrosis
N17.1 Acute kidney failure with acute cortical necrosis
N17.2 Acute kidney failure with medullary necrosis
N17.8 Other acute kidney failure
N17.9 Acute kidney failure, unspecified
N18.4 Chronic kidney disease, stage 4 (severe)
N18.5 Chronic kidney disease, stage 5
N18.6 End stage renal disease
N19* Unspecified kidney failure
N26.2 Page kidney
Q21.11 Secundum atrial septal defect
Q21.12 Patent foramen ovale
Q21.13 Coronary sinus atrial septal defect
Q21.14 Superior sinus venosus atrial septal defect
Q21.15 Inferior sinus venosus atrial septal defect
Q21.16 Sinus venosus atrial septal defect, unspecified
Q21.19 Other specified atrial septal defect
R00.1* Bradycardia, unspecified
R06.1 Stridor
R09.1 Pleurisy
R44.0* Auditory hallucinations
R44.2* Other hallucinations
R44.3* Hallucinations, unspecified
R56.00 Simple febrile convulsions
R56.01 Complex febrile convulsions
R56.1 Post traumatic seizures
R56.9* Unspecified convulsions
R57.0 Cardiogenic shock
R57.1* Hypovolemic shock
R57.8* Other shock
R57.9 Shock, unspecified
R65.21 Severe sepsis with septic shock
T36.0X5A Adverse effect of penicillins, initial encounter
T36.0X5D Adverse effect of penicillins, subsequent encounter
T36.0X5S Adverse effect of penicillins, sequela
T36.1X5A Adverse effect of cephalosporins and other beta-lactam antibiotics, initial encounter
T36.1X5D Adverse effect of cephalosporins and other beta-lactam antibiotics, subsequent encounter
T36.1X5S Adverse effect of cephalosporins and other beta-lactam antibiotics, sequela
T36.2X5A Adverse effect of chloramphenicol group, initial encounter
T36.2X5D Adverse effect of chloramphenicol group, subsequent encounter
T36.2X5S Adverse effect of chloramphenicol group, sequela
T36.3X5A Adverse effect of macrolides, initial encounter
T36.3X5D Adverse effect of macrolides, subsequent encounter
T36.3X5S Adverse effect of macrolides, sequela
T36.4X5A Adverse effect of tetracyclines, initial encounter
T36.4X5D Adverse effect of tetracyclines, subsequent encounter
T36.4X5S Adverse effect of tetracyclines, sequela
T36.5X5A Adverse effect of aminoglycosides, initial encounter
T36.5X5D Adverse effect of aminoglycosides, subsequent encounter
T36.5X5S Adverse effect of aminoglycosides, sequela
T36.6X5A Adverse effect of rifampicins, initial encounter
T36.6X5D Adverse effect of rifampicins, subsequent encounter
T36.6X5S Adverse effect of rifampicins, sequela
T36.7X5A Adverse effect of antifungal antibiotics, systemically used, initial encounter
T36.7X5D Adverse effect of antifungal antibiotics, systemically used, subsequent encounter
T36.7X5S Adverse effect of antifungal antibiotics, systemically used, sequela
T36.8X5A Adverse effect of other systemic antibiotics, initial encounter
T36.8X5D Adverse effect of other systemic antibiotics, subsequent encounter
T36.8X5S Adverse effect of other systemic antibiotics, sequela
T36.95XA Adverse effect of unspecified systemic antibiotic, initial encounter
T36.95XD Adverse effect of unspecified systemic antibiotic, subsequent encounter
T36.95XS Adverse effect of unspecified systemic antibiotic, sequela
T37.0X5A Adverse effect of sulfonamides, initial encounter
T37.0X5D Adverse effect of sulfonamides, subsequent encounter
T37.0X5S Adverse effect of sulfonamides, sequela
T37.1X5A Adverse effect of antimycobacterial drugs, initial encounter
T37.1X5D Adverse effect of antimycobacterial drugs, subsequent encounter
T37.1X5S Adverse effect of antimycobacterial drugs, sequela
T37.2X5A Adverse effect of antimalarials and drugs acting on other blood protozoa, initial encounter
T37.2X5D Adverse effect of antimalarials and drugs acting on other blood protozoa, subsequent encounter
T37.2X5S Adverse effect of antimalarials and drugs acting on other blood protozoa, sequela
T37.3X5A Adverse effect of other antiprotozoal drugs, initial encounter
T37.3X5D Adverse effect of other antiprotozoal drugs, subsequent encounter
T37.3X5S Adverse effect of other antiprotozoal drugs, sequela
T37.4X5A Adverse effect of anthelminthics, initial encounter
T37.4X5D Adverse effect of anthelminthics, subsequent encounter
T37.4X5S Adverse effect of anthelminthics, sequela
T37.5X5A Adverse effect of antiviral drugs, initial encounter
T37.5X5D Adverse effect of antiviral drugs, subsequent encounter
T37.5X5S Adverse effect of antiviral drugs, sequela
T37.8X5A Adverse effect of other specified systemic anti-infectives and antiparasitics, initial encounter
T37.8X5D Adverse effect of other specified systemic anti-infectives and antiparasitics, subsequent encounter
T37.8X5S Adverse effect of other specified systemic anti-infectives and antiparasitics, sequela
T37.95XA Adverse effect of unspecified systemic anti-infective and antiparasitic, initial encounter
T37.95XD Adverse effect of unspecified systemic anti-infective and antiparasitic, subsequent encounter
T37.95XS Adverse effect of unspecified systemic anti-infective and antiparasitic, sequela
T38.0X5A Adverse effect of glucocorticoids and synthetic analogues, initial encounter
T38.0X5D Adverse effect of glucocorticoids and synthetic analogues, subsequent encounter
T38.0X5S Adverse effect of glucocorticoids and synthetic analogues, sequela
T38.1X5A Adverse effect of thyroid hormones and substitutes, initial encounter
T38.1X5D Adverse effect of thyroid hormones and substitutes, subsequent encounter
T38.1X5S Adverse effect of thyroid hormones and substitutes, sequela
T38.2X5A Adverse effect of antithyroid drugs, initial encounter
T38.2X5D Adverse effect of antithyroid drugs, subsequent encounter
T38.2X5S Adverse effect of antithyroid drugs, sequela
T38.4X5A Adverse effect of oral contraceptives, initial encounter
T38.4X5D Adverse effect of oral contraceptives, subsequent encounter
T38.4X5S Adverse effect of oral contraceptives, sequela
T38.5X5A Adverse effect of other estrogens and progestogens, initial encounter
T38.5X5D Adverse effect of other estrogens and progestogens, subsequent encounter
T38.5X5S Adverse effect of other estrogens and progestogens, sequela
T38.6X5A Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, initial encounter
T38.6X5D Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, subsequent encounter
T38.6X5S Adverse effect of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, sequela
T38.7X5A Adverse effect of androgens and anabolic congeners, initial encounter
T38.7X5D Adverse effect of androgens and anabolic congeners, subsequent encounter
T38.7X5S Adverse effect of androgens and anabolic congeners, sequela
T38.805A Adverse effect of unspecified hormones and synthetic substitutes, initial encounter
T38.805D Adverse effect of unspecified hormones and synthetic substitutes, subsequent encounter
T38.805S Adverse effect of unspecified hormones and synthetic substitutes, sequela
T38.815A Adverse effect of anterior pituitary [adenohypophyseal] hormones, initial encounter
T38.815D Adverse effect of anterior pituitary [adenohypophyseal] hormones, subsequent encounter
T38.815S Adverse effect of anterior pituitary [adenohypophyseal] hormones, sequela
T38.895A Adverse effect of other hormones and synthetic substitutes, initial encounter
T38.895D Adverse effect of other hormones and synthetic substitutes, subsequent encounter
T38.895S Adverse effect of other hormones and synthetic substitutes, sequela
T38.905A Adverse effect of unspecified hormone antagonists, initial encounter
T38.905D Adverse effect of unspecified hormone antagonists, subsequent encounter
T38.905S Adverse effect of unspecified hormone antagonists, sequela
T38.995A Adverse effect of other hormone antagonists, initial encounter
T38.995D Adverse effect of other hormone antagonists, subsequent encounter
T38.995S Adverse effect of other hormone antagonists, sequela
T39.015A Adverse effect of aspirin, initial encounter
T39.015D Adverse effect of aspirin, subsequent encounter
T39.015S Adverse effect of aspirin, sequela
T39.095A Adverse effect of salicylates, initial encounter
T39.095D Adverse effect of salicylates, subsequent encounter
T39.095S Adverse effect of salicylates, sequela
T39.1X5A Adverse effect of 4-Aminophenol derivatives, initial encounter
T39.1X5D Adverse effect of 4-Aminophenol derivatives, subsequent encounter
T39.1X5S Adverse effect of 4-Aminophenol derivatives, sequela
T39.2X5A Adverse effect of pyrazolone derivatives, initial encounter
T39.2X5D Adverse effect of pyrazolone derivatives, subsequent encounter
T39.2X5S Adverse effect of pyrazolone derivatives, sequela
T39.315A Adverse effect of propionic acid derivatives, initial encounter
T39.315D Adverse effect of propionic acid derivatives, subsequent encounter
T39.315S Adverse effect of propionic acid derivatives, sequela
T39.395A Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], initial encounter
T39.395D Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], subsequent encounter
T39.395S Adverse effect of other nonsteroidal anti-inflammatory drugs [NSAID], sequela
T39.4X5A Adverse effect of antirheumatics, not elsewhere classified, initial encounter
T39.4X5D Adverse effect of antirheumatics, not elsewhere classified, subsequent encounter
T39.4X5S Adverse effect of antirheumatics, not elsewhere classified, sequela
T39.8X5A Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, initial encounter
T39.8X5D Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, subsequent encounter
T39.8X5S Adverse effect of other nonopioid analgesics and antipyretics, not elsewhere classified, sequela
T39.95XA Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, initial encounter
T39.95XD Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, subsequent encounter
T39.95XS Adverse effect of unspecified nonopioid analgesic, antipyretic and antirheumatic, sequela
T40.0X5A Adverse effect of opium, initial encounter
T40.0X5D Adverse effect of opium, subsequent encounter
T40.0X5S Adverse effect of opium, sequela
T40.2X5A Adverse effect of other opioids, initial encounter
T40.2X5D Adverse effect of other opioids, subsequent encounter
T40.2X5S Adverse effect of other opioids, sequela
T40.3X5A Adverse effect of methadone, initial encounter
T40.3X5D Adverse effect of methadone, subsequent encounter
T40.3X5S Adverse effect of methadone, sequela
T40.495A Adverse effect of other synthetic narcotics, initial encounter
T40.495D Adverse effect of other synthetic narcotics, subsequent encounter
T40.495S Adverse effect of other synthetic narcotics, sequela
T40.5X5A Adverse effect of cocaine, initial encounter
T40.5X5D Adverse effect of cocaine, subsequent encounter
T40.5X5S Adverse effect of cocaine, sequela
T40.605A Adverse effect of unspecified narcotics, initial encounter
T40.605D Adverse effect of unspecified narcotics, subsequent encounter
T40.605S Adverse effect of unspecified narcotics, sequela
T40.695A Adverse effect of other narcotics, initial encounter
T40.695D Adverse effect of other narcotics, subsequent encounter
T40.695S Adverse effect of other narcotics, sequela
T40.715A Adverse effect of cannabis, initial encounter
T40.715D Adverse effect of cannabis, subsequent encounter
T40.715S Adverse effect of cannabis, sequela
T40.905A Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter
T40.905D Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter
T40.905S Adverse effect of unspecified psychodysleptics [hallucinogens], sequela
T40.995A Adverse effect of other psychodysleptics [hallucinogens], initial encounter
T40.995D Adverse effect of other psychodysleptics [hallucinogens], subsequent encounter
T40.995S Adverse effect of other psychodysleptics [hallucinogens], sequela
T41.0X5A Adverse effect of inhaled anesthetics, initial encounter
T41.0X5D Adverse effect of inhaled anesthetics, subsequent encounter
T41.0X5S Adverse effect of inhaled anesthetics, sequela
T41.1X5A Adverse effect of intravenous anesthetics, initial encounter
T41.1X5D Adverse effect of intravenous anesthetics, subsequent encounter
T41.1X5S Adverse effect of intravenous anesthetics, sequela
T41.205A Adverse effect of unspecified general anesthetics, initial encounter
T41.205D Adverse effect of unspecified general anesthetics, subsequent encounter
T41.205S Adverse effect of unspecified general anesthetics, sequela
T41.295A Adverse effect of other general anesthetics, initial encounter
T41.295D Adverse effect of other general anesthetics, subsequent encounter
T41.295S Adverse effect of other general anesthetics, sequela
T41.3X5A Adverse effect of local anesthetics, initial encounter
T41.3X5D Adverse effect of local anesthetics, subsequent encounter
T41.3X5S Adverse effect of local anesthetics, sequela
T41.45XA Adverse effect of unspecified anesthetic, initial encounter
T41.45XD Adverse effect of unspecified anesthetic, subsequent encounter
T41.45XS Adverse effect of unspecified anesthetic, sequela
T41.5X5A Adverse effect of therapeutic gases, initial encounter
T41.5X5D Adverse effect of therapeutic gases, subsequent encounter
T41.5X5S Adverse effect of therapeutic gases, sequela
T42.0X5A Adverse effect of hydantoin derivatives, initial encounter
T42.0X5D Adverse effect of hydantoin derivatives, subsequent encounter
T42.0X5S Adverse effect of hydantoin derivatives, sequela
T42.1X5A Adverse effect of iminostilbenes, initial encounter
T42.1X5D Adverse effect of iminostilbenes, subsequent encounter
T42.1X5S Adverse effect of iminostilbenes, sequela
T42.2X5A Adverse effect of succinimides and oxazolidinediones, initial encounter
T42.2X5D Adverse effect of succinimides and oxazolidinediones, subsequent encounter
T42.2X5S Adverse effect of succinimides and oxazolidinediones, sequela
T42.3X5A Adverse effect of barbiturates, initial encounter
T42.3X5D Adverse effect of barbiturates, subsequent encounter
T42.3X5S Adverse effect of barbiturates, sequela
T42.4X5A Adverse effect of benzodiazepines, initial encounter
T42.4X5D Adverse effect of benzodiazepines, subsequent encounter
T42.4X5S Adverse effect of benzodiazepines, sequela
T42.5X5A Adverse effect of mixed antiepileptics, initial encounter
T42.5X5D Adverse effect of mixed antiepileptics, subsequent encounter
T42.5X5S Adverse effect of mixed antiepileptics, sequela
T42.6X5A Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
T42.6X5D Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
T42.6X5S Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela
T42.75XA Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
T42.75XD Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
T42.75XS Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela
T42.8X5A Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
T42.8X5D Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
T42.8X5S Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela
T43.015A Adverse effect of tricyclic antidepressants, initial encounter
T43.015D Adverse effect of tricyclic antidepressants, subsequent encounter
T43.015S Adverse effect of tricyclic antidepressants, sequela
T43.025A Adverse effect of tetracyclic antidepressants, initial encounter
T43.025D Adverse effect of tetracyclic antidepressants, subsequent encounter
T43.025S Adverse effect of tetracyclic antidepressants, sequela
T43.1X5A Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
T43.1X5D Adverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
T43.1X5S Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela
T43.205A Adverse effect of unspecified antidepressants, initial encounter
T43.205D Adverse effect of unspecified antidepressants, subsequent encounter
T43.205S Adverse effect of unspecified antidepressants, sequela
T43.215A Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
T43.215D Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
T43.215S Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela
T43.225A Adverse effect of selective serotonin reuptake inhibitors, initial encounter
T43.225D Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter
T43.225S Adverse effect of selective serotonin reuptake inhibitors, sequela
T43.295A Adverse effect of other antidepressants, initial encounter
T43.295D Adverse effect of other antidepressants, subsequent encounter
T43.295S Adverse effect of other antidepressants, sequela
T43.3X5A Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
T43.3X5D Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter
T43.3X5S Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela
T43.4X5A Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
T43.4X5D Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter
T43.4X5S Adverse effect of butyrophenone and thiothixene neuroleptics, sequela
T43.505A Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter
T43.505D Adverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter
T43.505S Adverse effect of unspecified antipsychotics and neuroleptics, sequela
T43.595A Adverse effect of other antipsychotics and neuroleptics, initial encounter
T43.595D Adverse effect of other antipsychotics and neuroleptics, subsequent encounter
T43.595S Adverse effect of other antipsychotics and neuroleptics, sequela
T43.605A Adverse effect of unspecified psychostimulants, initial encounter
T43.605D Adverse effect of unspecified psychostimulants, subsequent encounter
T43.605S Adverse effect of unspecified psychostimulants, sequela
T43.615A Adverse effect of caffeine, initial encounter
T43.615D Adverse effect of caffeine, subsequent encounter
T43.615S Adverse effect of caffeine, sequela
T43.625A Adverse effect of amphetamines, initial encounter
T43.625D Adverse effect of amphetamines, subsequent encounter
T43.625S Adverse effect of amphetamines, sequela
T43.635A Adverse effect of methylphenidate, initial encounter
T43.635D Adverse effect of methylphenidate, subsequent encounter
T43.635S Adverse effect of methylphenidate, sequela
T43.695A Adverse effect of other psychostimulants, initial encounter
T43.695D Adverse effect of other psychostimulants, subsequent encounter
T43.695S Adverse effect of other psychostimulants, sequela
T43.8X5A Adverse effect of other psychotropic drugs, initial encounter
T43.8X5D Adverse effect of other psychotropic drugs, subsequent encounter
T43.8X5S Adverse effect of other psychotropic drugs, sequela
T43.95XA Adverse effect of unspecified psychotropic drug, initial encounter
T43.95XD Adverse effect of unspecified psychotropic drug, subsequent encounter
T43.95XS Adverse effect of unspecified psychotropic drug, sequela
T44.0X5A Adverse effect of anticholinesterase agents, initial encounter
T44.0X5D Adverse effect of anticholinesterase agents, subsequent encounter
T44.0X5S Adverse effect of anticholinesterase agents, sequela
T44.1X5A Adverse effect of other parasympathomimetics [cholinergics], initial encounter
T44.1X5D Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter
T44.1X5S Adverse effect of other parasympathomimetics [cholinergics], sequela
T44.2X5A Adverse effect of ganglionic blocking drugs, initial encounter
T44.2X5D Adverse effect of ganglionic blocking drugs, subsequent encounter
T44.2X5S Adverse effect of ganglionic blocking drugs, sequela
T44.3X5A Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter
T44.3X5D Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter
T44.3X5S Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela
T44.4X5A Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter
T44.4X5D Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter
T44.4X5S Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela
T44.5X5A Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter
T44.5X5D Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter
T44.5X5S Adverse effect of predominantly beta-adrenoreceptor agonists, sequela
T44.6X5A Adverse effect of alpha-adrenoreceptor antagonists, initial encounter
T44.6X5D Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter
T44.6X5S Adverse effect of alpha-adrenoreceptor antagonists, sequela
T44.7X5A Adverse effect of beta-adrenoreceptor antagonists, initial encounter
T44.7X5D Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter
T44.7X5S Adverse effect of beta-adrenoreceptor antagonists, sequela
T44.8X5A Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter
T44.8X5D Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter
T44.8X5S Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela
T44.905A Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter
T44.905D Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter
T44.905S Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela
T45.0X5A Adverse effect of antiallergic and antiemetic drugs, initial encounter
T45.0X5D Adverse effect of antiallergic and antiemetic drugs, subsequent encounter
T45.0X5S Adverse effect of antiallergic and antiemetic drugs, sequela
T45.1X5A Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter
T45.1X5D Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter
T45.1X5S Adverse effect of antineoplastic and immunosuppressive drugs, sequela
T45.2X5A Adverse effect of vitamins, initial encounter
T45.2X5D Adverse effect of vitamins, subsequent encounter
T45.2X5S Adverse effect of vitamins, sequela
T45.3X5A Adverse effect of enzymes, initial encounter
T45.3X5D Adverse effect of enzymes, subsequent encounter
T45.3X5S Adverse effect of enzymes, sequela
T45.4X5A Adverse effect of iron and its compounds, initial encounter
T45.4X5D Adverse effect of iron and its compounds, subsequent encounter
T45.4X5S Adverse effect of iron and its compounds, sequela
T45.515A Adverse effect of anticoagulants, initial encounter
T45.515D Adverse effect of anticoagulants, subsequent encounter
T45.515S Adverse effect of anticoagulants, sequela
T45.525A Adverse effect of antithrombotic drugs, initial encounter
T45.525D Adverse effect of antithrombotic drugs, subsequent encounter
T45.525S Adverse effect of antithrombotic drugs, sequela
T45.605A Adverse effect of unspecified fibrinolysis-affecting drugs, initial encounter
T45.605D Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter
T45.605S Adverse effect of unspecified fibrinolysis-affecting drugs, sequela
T45.615A Adverse effect of thrombolytic drugs, initial encounter
T45.615D Adverse effect of thrombolytic drugs, subsequent encounter
T45.615S Adverse effect of thrombolytic drugs, sequela
T45.625A Adverse effect of hemostatic drug, initial encounter
T45.625D Adverse effect of hemostatic drug, subsequent encounter
T45.625S Adverse effect of hemostatic drug, sequela
T45.695A Adverse effect of other fibrinolysis-affecting drugs, initial encounter
T45.695D Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter
T45.695S Adverse effect of other fibrinolysis-affecting drugs, sequela
T45.7X5A Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter
T45.7X5D Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter
T45.7X5S Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela
T45.8X5A Adverse effect of other primarily systemic and hematological agents, initial encounter
T45.8X5D Adverse effect of other primarily systemic and hematological agents, subsequent encounter
T45.8X5S Adverse effect of other primarily systemic and hematological agents, sequela
T45.95XA Adverse effect of unspecified primarily systemic and hematological agent, initial encounter
T45.95XD Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter
T45.95XS Adverse effect of unspecified primarily systemic and hematological agent, sequela
T46.0X5A Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T46.0X5D Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
T46.0X5S Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
T46.1X5A Adverse effect of calcium-channel blockers, initial encounter
T46.1X5D Adverse effect of calcium-channel blockers, subsequent encounter
T46.1X5S Adverse effect of calcium-channel blockers, sequela
T46.2X5A Adverse effect of other antidysrhythmic drugs, initial encounter
T46.2X5D Adverse effect of other antidysrhythmic drugs, subsequent encounter
T46.2X5S Adverse effect of other antidysrhythmic drugs, sequela
T46.3X5A Adverse effect of coronary vasodilators, initial encounter
T46.3X5D Adverse effect of coronary vasodilators, subsequent encounter
T46.3X5S Adverse effect of coronary vasodilators, sequela
T46.4X5A Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
T46.4X5D Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
T46.4X5S Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
T46.5X5A Adverse effect of other antihypertensive drugs, initial encounter
T46.5X5D Adverse effect of other antihypertensive drugs, subsequent encounter
T46.5X5S Adverse effect of other antihypertensive drugs, sequela
T46.6X5A Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
T46.6X5D Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
T46.6X5S Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
T46.7X5A Adverse effect of peripheral vasodilators, initial encounter
T46.7X5D Adverse effect of peripheral vasodilators, subsequent encounter
T46.7X5S Adverse effect of peripheral vasodilators, sequela
T46.8X5A Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
T46.8X5D Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
T46.8X5S Adverse effect of antivaricose drugs, including sclerosing agents, sequela
T46.905A Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
T46.905D Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
T46.905S Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
T46.995A Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
T46.995D Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
T46.995S Adverse effect of other agents primarily affecting the cardiovascular system, sequela
T47.0X5A Adverse effect of histamine H2-receptor blockers, initial encounter
T47.0X5D Adverse effect of histamine H2-receptor blockers, subsequent encounter
T47.0X5S Adverse effect of histamine H2-receptor blockers, sequela
T47.1X5A Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter
T47.1X5D Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter
T47.1X5S Adverse effect of other antacids and anti-gastric-secretion drugs, sequela
T47.2X5A Adverse effect of stimulant laxatives, initial encounter
T47.2X5D Adverse effect of stimulant laxatives, subsequent encounter
T47.2X5S Adverse effect of stimulant laxatives, sequela
T47.3X5A Adverse effect of saline and osmotic laxatives, initial encounter
T47.3X5D Adverse effect of saline and osmotic laxatives, subsequent encounter
T47.3X5S Adverse effect of saline and osmotic laxatives, sequela
T47.4X5A Adverse effect of other laxatives, initial encounter
T47.4X5D Adverse effect of other laxatives, subsequent encounter
T47.4X5S Adverse effect of other laxatives, sequela
T47.5X5A Adverse effect of digestants, initial encounter
T47.5X5D Adverse effect of digestants, subsequent encounter
T47.5X5S Adverse effect of digestants, sequela
T47.6X5A Adverse effect of antidiarrheal drugs, initial encounter
T47.6X5D Adverse effect of antidiarrheal drugs, subsequent encounter
T47.6X5S Adverse effect of antidiarrheal drugs, sequela
T47.7X5A Adverse effect of emetics, initial encounter
T47.7X5D Adverse effect of emetics, subsequent encounter
T47.7X5S Adverse effect of emetics, sequela
T47.8X5A Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter
T47.8X5D Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter
T47.8X5S Adverse effect of other agents primarily affecting gastrointestinal system, sequela
T47.95XA Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter
T47.95XD Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter
T47.95XS Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela
T48.0X5A Adverse effect of oxytocic drugs, initial encounter
T48.0X5D Adverse effect of oxytocic drugs, subsequent encounter
T48.0X5S Adverse effect of oxytocic drugs, sequela
T48.1X5A Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter
T48.1X5D Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter
T48.1X5S Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela
T48.205A Adverse effect of unspecified drugs acting on muscles, initial encounter
T48.205D Adverse effect of unspecified drugs acting on muscles, subsequent encounter
T48.205S Adverse effect of unspecified drugs acting on muscles, sequela
T48.295A Adverse effect of other drugs acting on muscles, initial encounter
T48.295D Adverse effect of other drugs acting on muscles, subsequent encounter
T48.295S Adverse effect of other drugs acting on muscles, sequela
T48.3X5A Adverse effect of antitussives, initial encounter
T48.3X5D Adverse effect of antitussives, subsequent encounter
T48.3X5S Adverse effect of antitussives, sequela
T48.4X5A Adverse effect of expectorants, initial encounter
T48.4X5D Adverse effect of expectorants, subsequent encounter
T48.4X5S Adverse effect of expectorants, sequela
T48.5X5A Adverse effect of other anti-common-cold drugs, initial encounter
T48.5X5D Adverse effect of other anti-common-cold drugs, subsequent encounter
T48.5X5S Adverse effect of other anti-common-cold drugs, sequela
T48.6X5A Adverse effect of antiasthmatics, initial encounter
T48.6X5D Adverse effect of antiasthmatics, subsequent encounter
T48.6X5S Adverse effect of antiasthmatics, sequela
T48.905A Adverse effect of unspecified agents primarily acting on the respiratory system, initial encounter
T48.905D Adverse effect of unspecified agents primarily acting on the respiratory system, subsequent encounter
T48.905S Adverse effect of unspecified agents primarily acting on the respiratory system, sequela
T48.995A Adverse effect of other agents primarily acting on the respiratory system, initial encounter
T48.995D Adverse effect of other agents primarily acting on the respiratory system, subsequent encounter
T48.995S Adverse effect of other agents primarily acting on the respiratory system, sequela
T49.0X5A Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, initial encounter
T49.0X5D Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, subsequent encounter
T49.0X5S Adverse effect of local antifungal, anti-infective and anti-inflammatory drugs, sequela
T49.1X5A Adverse effect of antipruritics, initial encounter
T49.1X5D Adverse effect of antipruritics, subsequent encounter
T49.1X5S Adverse effect of antipruritics, sequela
T49.2X5A Adverse effect of local astringents and local detergents, initial encounter
T49.2X5D Adverse effect of local astringents and local detergents, subsequent encounter
T49.2X5S Adverse effect of local astringents and local detergents, sequela
T49.3X5A Adverse effect of emollients, demulcents and protectants, initial encounter
T49.3X5D Adverse effect of emollients, demulcents and protectants, subsequent encounter
T49.3X5S Adverse effect of emollients, demulcents and protectants, sequela
T49.4X5A Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, initial encounter
T49.4X5D Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, subsequent encounter
T49.4X5S Adverse effect of keratolytics, keratoplastics, and other hair treatment drugs and preparations, sequela
T49.5X5A Adverse effect of ophthalmological drugs and preparations, initial encounter
T49.5X5D Adverse effect of ophthalmological drugs and preparations, subsequent encounter
T49.5X5S Adverse effect of ophthalmological drugs and preparations, sequela
T49.6X5A Adverse effect of otorhinolaryngological drugs and preparations, initial encounter
T49.6X5D Adverse effect of otorhinolaryngological drugs and preparations, subsequent encounter
T49.6X5S Adverse effect of otorhinolaryngological drugs and preparations, sequela
T49.7X5A Adverse effect of dental drugs, topically applied, initial encounter
T49.7X5D Adverse effect of dental drugs, topically applied, subsequent encounter
T49.7X5S Adverse effect of dental drugs, topically applied, sequela
T49.8X5A Adverse effect of other topical agents, initial encounter
T49.8X5D Adverse effect of other topical agents, subsequent encounter
T49.8X5S Adverse effect of other topical agents, sequela
T49.95XA Adverse effect of unspecified topical agent, initial encounter
T49.95XD Adverse effect of unspecified topical agent, subsequent encounter
T49.95XS Adverse effect of unspecified topical agent, sequela
T50.0X5A Adverse effect of mineralocorticoids and their antagonists, initial encounter
T50.0X5D Adverse effect of mineralocorticoids and their antagonists, subsequent encounter
T50.0X5S Adverse effect of mineralocorticoids and their antagonists, sequela
T50.1X5A Adverse effect of loop [high-ceiling] diuretics, initial encounter
T50.1X5D Adverse effect of loop [high-ceiling] diuretics, subsequent encounter
T50.1X5S Adverse effect of loop [high-ceiling] diuretics, sequela
T50.2X5A Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
T50.2X5D Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
T50.2X5S Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
T50.3X5A Adverse effect of electrolytic, caloric and water-balance agents, initial encounter
T50.3X5D Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter
T50.3X5S Adverse effect of electrolytic, caloric and water-balance agents, sequela
T50.4X5A Adverse effect of drugs affecting uric acid metabolism, initial encounter
T50.4X5D Adverse effect of drugs affecting uric acid metabolism, subsequent encounter
T50.4X5S Adverse effect of drugs affecting uric acid metabolism, sequela
T50.5X5A Adverse effect of appetite depressants, initial encounter
T50.5X5D Adverse effect of appetite depressants, subsequent encounter
T50.5X5S Adverse effect of appetite depressants, sequela
T50.6X5A Adverse effect of antidotes and chelating agents, initial encounter
T50.6X5D Adverse effect of antidotes and chelating agents, subsequent encounter
T50.6X5S Adverse effect of antidotes and chelating agents, sequela
T50.7X5A Adverse effect of analeptics and opioid receptor antagonists, initial encounter
T50.7X5D Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter
T50.7X5S Adverse effect of analeptics and opioid receptor antagonists, sequela
T50.8X5A Adverse effect of diagnostic agents, initial encounter
T50.8X5D Adverse effect of diagnostic agents, subsequent encounter
T50.8X5S Adverse effect of diagnostic agents, sequela
T50.A15A Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter
T50.A15D Adverse effect of pertussis vaccine, including combinations with a pertussis component, subsequent encounter
T50.A15S Adverse effect of pertussis vaccine, including combinations with a pertussis component, sequela
T50.A25A Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter
T50.A25D Adverse effect of mixed bacterial vaccines without a pertussis component, subsequent encounter
T50.A25S Adverse effect of mixed bacterial vaccines without a pertussis component, sequela
T50.A95A Adverse effect of other bacterial vaccines, initial encounter
T50.A95D Adverse effect of other bacterial vaccines, subsequent encounter
T50.A95S Adverse effect of other bacterial vaccines, sequela
T50.B15A Adverse effect of smallpox vaccines, initial encounter
T50.B15D Adverse effect of smallpox vaccines, subsequent encounter
T50.B15S Adverse effect of smallpox vaccines, sequela
T50.B95A Adverse effect of other viral vaccines, initial encounter
T50.B95D Adverse effect of other viral vaccines, subsequent encounter
T50.B95S Adverse effect of other viral vaccines, sequela
T50.Z15A Adverse effect of immunoglobulin, initial encounter
T50.Z15D Adverse effect of immunoglobulin, subsequent encounter
T50.Z15S Adverse effect of immunoglobulin, sequela
T50.Z95A Adverse effect of other vaccines and biological substances, initial encounter
T50.Z95D Adverse effect of other vaccines and biological substances, subsequent encounter
T50.Z95S Adverse effect of other vaccines and biological substances, sequela
T50.905A Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter
T50.905D Adverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter
T50.905S Adverse effect of unspecified drugs, medicaments and biological substances, sequela
T50.995A Adverse effect of other drugs, medicaments and biological substances, initial encounter
T50.995D Adverse effect of other drugs, medicaments and biological substances, subsequent encounter
T50.995S Adverse effect of other drugs, medicaments and biological substances, sequela
T78.00XA Anaphylactic reaction due to unspecified food, initial encounter
T78.00XD Anaphylactic reaction due to unspecified food, subsequent encounter
T78.00XS Anaphylactic reaction due to unspecified food, sequela
T78.01XA Anaphylactic reaction due to peanuts, initial encounter
T78.01XD Anaphylactic reaction due to peanuts, subsequent encounter
T78.01XS Anaphylactic reaction due to peanuts, sequela
T78.02XA Anaphylactic reaction due to shellfish (crustaceans), initial encounter
T78.02XD Anaphylactic reaction due to shellfish (crustaceans), subsequent encounter
T78.02XS Anaphylactic reaction due to shellfish (crustaceans), sequela
T78.03XA Anaphylactic reaction due to other fish, initial encounter
T78.03XD Anaphylactic reaction due to other fish, subsequent encounter
T78.03XS Anaphylactic reaction due to other fish, sequela
T78.04XA Anaphylactic reaction due to fruits and vegetables, initial encounter
T78.04XD Anaphylactic reaction due to fruits and vegetables, subsequent encounter
T78.04XS Anaphylactic reaction due to fruits and vegetables, sequela
T78.05XA Anaphylactic reaction due to tree nuts and seeds, initial encounter
T78.05XD Anaphylactic reaction due to tree nuts and seeds, subsequent encounter
T78.05XS Anaphylactic reaction due to tree nuts and seeds, sequela
T78.06XA Anaphylactic reaction due to food additives, initial encounter
T78.06XD Anaphylactic reaction due to food additives, subsequent encounter
T78.06XS Anaphylactic reaction due to food additives, sequela
T78.07XA Anaphylactic reaction due to milk and dairy products, initial encounter
T78.07XD Anaphylactic reaction due to milk and dairy products, subsequent encounter
T78.07XS Anaphylactic reaction due to milk and dairy products, sequela
T78.08XA Anaphylactic reaction due to eggs, initial encounter
T78.08XD Anaphylactic reaction due to eggs, subsequent encounter
T78.08XS Anaphylactic reaction due to eggs, sequela
T78.09XA Anaphylactic reaction due to other food products, initial encounter
T78.09XD Anaphylactic reaction due to other food products, subsequent encounter
T78.09XS Anaphylactic reaction due to other food products, sequela
T78.2XXA Anaphylactic shock, unspecified, initial encounter
T78.2XXD Anaphylactic shock, unspecified, subsequent encounter
T78.2XXS Anaphylactic shock, unspecified, sequela
T78.3XXA Angioneurotic edema, initial encounter
T78.3XXD Angioneurotic edema, subsequent encounter
T78.3XXS Angioneurotic edema, sequela
T78.40XA Allergy, unspecified, initial encounter
T78.40XD Allergy, unspecified, subsequent encounter
T78.40XS Allergy, unspecified, sequela
T78.41XA Arthus phenomenon, initial encounter
T78.41XD Arthus phenomenon, subsequent encounter
T78.41XS Arthus phenomenon, sequela
T78.49XA Other allergy, initial encounter
T78.49XD Other allergy, subsequent encounter
T78.49XS Other allergy, sequela
T81.81XA Complication of inhalation therapy, initial encounter
T81.81XD Complication of inhalation therapy, subsequent encounter
T81.81XS Complication of inhalation therapy, sequela
T81.9XXA Unspecified complication of procedure, initial encounter
T81.9XXD Unspecified complication of procedure, subsequent encounter
T81.9XXS Unspecified complication of procedure, sequela
T88.2XXA Shock due to anesthesia, initial encounter
T88.2XXD Shock due to anesthesia, subsequent encounter
T88.2XXS Shock due to anesthesia, sequela
T88.4XXA Failed or difficult intubation, initial encounter
T88.4XXD Failed or difficult intubation, subsequent encounter
T88.4XXS Failed or difficult intubation, sequela
T88.52XA Failed moderate sedation during procedure, initial encounter
T88.52XD Failed moderate sedation during procedure, subsequent encounter
T88.52XS Failed moderate sedation during procedure, sequela
T88.59XA Other complications of anesthesia, initial encounter
T88.59XD Other complications of anesthesia, subsequent encounter
T88.59XS Other complications of anesthesia, sequela
T88.6XXA Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, initial encounter
T88.6XXD Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, subsequent encounter
T88.6XXS Anaphylactic reaction due to adverse effect of correct drug or medicament properly administered, sequela
T88.7XXA Unspecified adverse effect of drug or medicament, initial encounter
T88.7XXD Unspecified adverse effect of drug or medicament, subsequent encounter
T88.7XXS Unspecified adverse effect of drug or medicament, sequela
T88.8XXA Other specified complications of surgical and medical care, not elsewhere classified, initial encounter
T88.8XXD Other specified complications of surgical and medical care, not elsewhere classified, subsequent encounter
T88.8XXS Other specified complications of surgical and medical care, not elsewhere classified, sequela
T88.9XXA Complication of surgical and medical care, unspecified, initial encounter
T88.9XXD Complication of surgical and medical care, unspecified, subsequent encounter
T88.9XXS Complication of surgical and medical care, unspecified, sequela
Z79.3* Long term (current) use of hormonal contraceptives
Z79.891* Long term (current) use of opiate analgesic
Z79.899* Other long term (current) drug therapy
Z88.4 Allergy status to anesthetic agent
Z88.5 Allergy status to narcotic agent
Z88.6 Allergy status to analgesic agent
Z92.83 Personal history of failed moderate sedation
Z93.0 Tracheostomy status
Z99.81 Dependence on supplemental oxygen
Group 1 Medical Necessity ICD-10-CM Codes Asterisk Explanation

*Note: Use of the diagnosis codes A41.89-A41.9 must be representative of the patient’s acute sepsis condition.

*Note: Use of the diagnosis codes E27.8-E27.9, E35 must be representative of the patient’s severe metabolic condition (e.g., a greatly elevated blood sugar, such as 300 mg.).

*Note: Use of the diagnosis codes E87.5-E87.6, E87.8 must be representative of the patient’s electrolyte imbalance (e.g., sodium, potassium or calcium levels, etc., significantly outside normal limits).

*Note: Use of the diagnosis codes E84.0, E84.11, E84.9 would indicate that the patient has significant respiratory impairment related to this condition.

*Note: Use of diagnosis code E66.01 or E66.813 indicates the patient is at least two times ideal body weight.

*Note: Use of the diagnosis codes F84.5, F84.8 must be representative of the patient’s significant organic brain syndrome/dementia (with confusion or combative behavior) or psychotic condition.

*Note: Use of diagnosis code F44.9 must be representative of the patient’s severe anxiety, hysteria or panic attack condition supported by the need for and responses to sedative medication(s).

*Note: Use of diagnosis code F40.210, F40.218, F40.220, F40.228, F40.230-F40.233, F40.240-F40.243, F40.248, F40.290-F40.291, F40.298, F40.8 should represent that the patient has a severe phobic condition.

*Note: Use of the diagnosis codes F19.20-F19.21 must be representative of the patient’s drug dependency (acute, detoxification state) condition.

*Note: Use of the diagnosis codes F10.10, F10.120, F10.129 must be representative of the patient’s acute drunken condition.

*Note: Use of the diagnosis codes F19.10, F19.120, F19.90 must be representative of the patient’s drug abuse (acute, detoxification state) condition.

*Note: Use of the diagnosis codes G20.A1, G20.A2, G20.B1, G20.B2, G21.11, G21.19, G21.2-G21.4, G21.8-G21.9 must be representative of the patient’s condition.

*Note: Use of the diagnosis code G35 would be indicative of the patient’s having significant neurological impairment due to multiple sclerosis.

*Note: Use of the diagnosis code G80.9 must be representative of the patient’s condition.

*Note: Use of the diagnosis codes G40.901, G40.909, G40.911, G40.919 must be representative of the patient’s seizure disorder condition requiring appropriate antiepileptic medication.

*Note: Use of the diagnosis codes I01.0-I01.2 must be representative of the patient’s having an acute and unstable condition related to acute rheumatic cardiac disease.

*Note: Use of the diagnosis code I08.1-I08.3, I08.8-I08.9, I09.1 must be representative of the patient’s valvular heart disease condition (acute, symptomatic) supported by medical treatment and cardiac medications.

*Note: Use of the diagnosis code I10 must be representative of the patient’s condition (systolic pressure over 180 or diastolic over 110 and on more than two antihypertensive medications).

*Note: Use of the diagnosis codes I11.0, I11.9 must be representative of the patient’s having an acute and unstable condition requiring multiple medications.

*Note: Use of the diagnosis code I24.81, I24.89, I24.9 must be representative of the patient’s acute and unstable condition.

*Note: Use of the diagnosis code I25.2 must be representative of the patient’s acute and unstable (e.g., multiple medications) ischemic heart disease/condition.

*Note: Use of the diagnosis codes I25.5, I25.6, I25.85, I25.89, I25.9 must be representative of the patient’s condition.

*Note: Use of the diagnosis code I27.81, I27.9 must be representative of the patient’s severe pulmonary condition.

*Note: Use of the diagnosis code I38 must be representative of the patient’s acute and unstable heart disease/condition requiring multiple medications.

*Note: I42.7, I42.9, I43 Use of the diagnosis codes in the section above must be representative of the patient’s severely impaired condition requiring multiple medications.

*Note: Use of the diagnosis code I45.9 must be representative of the patient’s significant life threatening arrhythmia condition, such as ventricular rhythms.

*Note: Use of the diagnosis code I49.8, R00.1 must be representative of the patient’s significant arrhythmic condition, supported by history and diagnosis and use of appropriate treatment.

*Note: Use of the diagnosis codes I50.810, I50.811, I50.812, I50.813, I50.814, I50.82, I50.83, I50.84, I50.89, and I50.9 must be representative of the patient’s significant heart failure condition supported by the patient being on pulmonary and/or cardiac medications.

*Note: Use of the diagnosis codes G45.4, G46.3-G46.8, I67.1-I67.2, I67.4-I67.7, I67.81-I67.82, I67.89-I67.9, I68.0, I68.2, I68.8 must be representative of the patient’s acutely impaired condition supported by diagnosis and treatment.

*Note: Use of the diagnosis codes J80, J96.00-J96.02, J96.90-J96.92 must be representative of the patient’s condition.

*Note: Use of the diagnosis codes K85.00-K85.32, K85.80-K85.92, K86.0-K86.1 must be representative of the patient’s hepatic failure condition (serum bilirubin greater than 3).

*Note: Use of the diagnosis code K92.2 must be representative of massive gastrointestinal bleeding (e.g., more than 500 cc. of acute blood loss).

*Note: Use of the diagnosis code N19 must be representative of the patient’s condition as acute renal failure or end stage renal disease on a dialysis program (serum creatinine level greater than 2).

*Note: Use of the diagnosis code R44.0, R44.2-R44.3 must be representative of the patient’s condition (supported by history and use of appropriate sedative medication).

*Note: Use of the diagnosis code R56.9 must be representative of the patient’s unstable condition requiring multiple medications.

*Note: Use of the diagnosis code R57.1, R57.8 must be indicative of systolic pressure under 90 mmHg.

*Note: With Z79.3, Z79.891, Z79.899 the medication, duration of use and dosage must be maintained in the medical record.

 

N/A

ICD-10-CM Codes that DO NOT Support Medical Necessity

Group 1

Group 1 Paragraph

All those not listed under the “ICD-10-CM Codes that Support Medical Necessity” section of this policy.

Group 1 Codes

N/A

N/A

ICD-10-PCS Codes

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

Additional ICD-10 Information

N/A

Bill Type Codes

Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type. Complete absence of all Bill Types indicates that coverage is not influenced by Bill Type and the article should be assumed to apply equally to all claims.

Code Description

Please accept the License to see the codes.

N/A

Revenue Codes

Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination. Complete absence of all Revenue Codes indicates that coverage is not influenced by Revenue Code and the article should be assumed to apply equally to all Revenue Codes.

Note: The contractor has identified the Bill Type and Revenue Codes applicable for use with the CPT/HCPCS codes included in this Article. Providers are reminded that not all the CPT/HCPCS codes listed can be billed with all Bill Type and/or Revenue Codes listed. CPT/HCPCS codes are required to be billed with specific Bill Type and Revenue Codes. Providers are encouraged to refer to the CMS IOM Pub. 100-04, Medicare Claims Processing Manual, for further guidance.


Code Description

Please accept the License to see the codes.

N/A

Other Coding Information

Group 1

Group 1 Paragraph

N/A

Group 1 Codes

N/A

N/A

Coding Table Information

Excluded CPT/HCPCS Codes - Table Format
Code Descriptor Generic Name Descriptor Brand Name Exclusion Effective Date Exclusion End Date Reason for Exclusion
N/A N/A
N/A
Non-Excluded CPT/HCPCS Ended Codes - Table Format
Code Descriptor Generic Name Descriptor Brand Name Exclusion Effective Date Exclusion End Date Reason for Exclusion
N/A

Revision History Information

Revision History Date Revision History Number Revision History Explanation
10/01/2024 R10

Article revised and published on 10/24/2024 effective for dates of service on and after 10/01/2024 to reflect annual ICD-10-CM code updates. The following ICD-10-CM codes that Support Medical Necessity in Group 1 have been added to the article: E16.A1, E16.A2, E16.A3, E66.813*, I26.03, and I26.04. Coding use of E66.813 was added to the E66.01 asterisk note in the Group 1 Medical Necessity ICD-10-CM Codes Asterisk Explanation section. Minor formatting changes were made throughout the article.

01/01/2024 R9

Article revised and published on 01/25/2024 effective for dates of service on and after 01/01/2024 to reflect the Annual HCPCS/CPT Code Updates. The following Group 1 code has a short descriptor change: 01999. 

10/01/2023 R8

Article revised and published on 10/26/2023 effective for dates of service on and after 10/01/2023 to reflect the Annual ICD-10-CM Code Updates. The following codes have been added to Group 1: A41.54, E20.810, E20.811, E20.812, E20.818, E20.89, G20.A1, G20.A2, G20.B1, G20.B2, I20.81, I20.89, I21.B, I24.81, I24.89, I25.85, I47.11, I47.19. The following codes have been deleted and therefore removed from the article: E20.8, G20, I20.8, I24.8, I47.1. For the following ICD-10-CM code, the code description has changed: I25.112 (Group 1 Codes).

10/01/2022 R7

Article revised and published on 10/20/2022 effective for dates of service on and after 10/01/2022 to reflect the Annual ICD-10-CM Code Updates. The following ICD-10-CM codes have been added to the Article in Group 1: E87.20, E87.21, E87.22, E87.29, F01.511, F01.518, F01.52, F01.53, F01.54, F01.A0, F01.A11, F01.A18, F01.A2, F01.A3, F01.A4, F01.B0, F01.B11, F01.B18, F01.B2, F01.B3, F01.B4, F01.C0, F01.C11, F01.C18, F01.C2, F01.C3, F01.C4, F02.811, F02.818, F02.82, F02.83, F02.84, F02.A0, F02.A11, F02.A18, F02.A2, F02.A3, F02.A4, F02.B0, F02.B11, F02.B18, F02.B2, F02.B3, F02.B4, F02.C0, F02.C11, F02.C18, F02.C2, F02.C3, F02.C4, F03.911, F03.918, F03.92, F03.93, F03.94, F03.A0, F03.A11, F03.A18, F03.A2, F03.A3, F03.A4, F03.B0, F03.B11, F03.B18, F03.B2, F03.B3, F03.B4, F03.C0, F03.C11, F03.C18, F03.C2, F03.C3, F03.C4, I20.2, I25.112, I25.702, I25.712, I25.722, I25.732, I25.752, I25.762, I25.792, I31.31, I31.39, I34.81, I34.89, I47.21, I47.29, Q21.11, Q21.12, Q21.13, Q21.14, Q21.15, Q21.16, Q21.19. The following ICD-10-CM codes have been deleted and therefore have been removed from the article in Group 1: E87.2, F01.51, F02.81, F03.91, I31.3, I34.8, I47.2, Q21.1. For the following ICD-10-CM codes the code description has changed in Group 1: F01.50, F02.80, F03.90.

In response to an inquiry, the ‘ICD-10-CM Codes that Support Medical Necessity’, ‘Group 1 Codes’ section has been revised to add an asterisk to codes I11.0, I11.9, I38, I42.9, I67.89, J96.00, J96.01, J96.02 and R00.1. The ‘Group 1 Asterisk Explanation’ section has been revised to add code G21.19 for the 12th note.

06/28/2022 R6

Article revised and published on 9/8/2022 to add a Note to the ICD-10-CM Codes Paragraph 1indicating that ICD-10-CM codes E87.2, F01.51, F02.81, F03.91, I31.3, I34.8, I47.2, and Q21.1 continue to be covered diagnoses. A "Document Note" has been added to the top of this article and to the top of the version published on 08/11/2022.

06/28/2022 R5

Article revised and published on 8/11/2022 effective for dates of service on and after 6/28/2022 in response to an inquiry. The following ICD-10-CM code was added to Group 1: J45.50. Documentation requirements were added under the coding guidance section. Minor formatting changes have been made throughout the article.

01/01/2022 R4

Article revised and published on 01/20/2022 effective for dates of service on and after 01/01/2022 to reflect the Annual HCPCS/CPT Code Updates. The following CPT codes have been added to Group 1 of the Article: 01937, 01938, 01939, 01940, 01941, 01942. The following CPT codes have been deleted and therefore have been removed from Group 1 of the article: 01935, 01936. Minor formatting changes have been made throughout the article.

10/01/2021 R3

Article revised and published on 10/14/2021 effective for dates of service on and after 10/01/2021 to reflect the Annual ICD-10-CM Code Updates. The following ICD-10-CM codes have been added to the article: F78.A9, T40.715A, T40.715D, and T40.715S in Group 1 Codes. The following ICD-10-CM codes have been deleted and therefore have been removed from the article: F78, T40.7X5A, T40.7X5D, and T40.7X5S in Group 1 Codes.

10/01/2020 R2

Article revised and published on 10/01/2020 effective for dates of service on and after 10/01/2020 to reflect the Annual ICD-10-CM Code Updates. The following ICD-10-CM codes have been added to the Article for Group 1 Codes: J82.81, J82.82, J82.83, J82.89, K74.01, K74.02, T40.495A, T40.495D, and T40.495S. The following ICD-10 codes have been deleted and therefore have been removed from the article: J82, K74.0, T40.4X5A, T40.4X5D, and T40.4X5S. The following ICD-10-CM codes have undergone a descriptor change: Z88.4, Z88.5, and Z88.6. Minor formatting changes made through the coding section.

10/01/2019 R1

Consistent with CMS Change Request 10901, a new billing and coding article was created and published on 10/17/2019 effective for dates of service on and after 10/01/2019. All codes and coding information have been moved from the related LCD to the article. In response to the Annual ICD-10-CM Code Update, the following ICD-10-CM codes have been deleted and therefore are not included in this article: I48.1 and I48.2. The following ICD-10-CM codes have been added to ICD-10 code group 1 of the Article: I48.11, I48.19, I48.20 and I48.21.

N/A

Associated Documents

Medicare BPM Ch 15.50.2 SAD Determinations
Medicare BPM Ch 15.50.2
Related Local Coverage Documents
LCDs
L35049 - Monitored Anesthesia Care
Related National Coverage Documents
N/A
SAD Process URL 1
N/A
SAD Process URL 2
N/A
Statutory Requirements URLs
N/A
Rules and Regulations URLs
N/A
CMS Manual Explanations URLs
N/A
Other URLs
N/A
Public Versions
Updated On Effective Dates Status
10/18/2024 10/01/2024 - N/A Currently in Effect You are here
01/19/2024 01/01/2024 - 09/30/2024 Superseded View
10/20/2023 10/01/2023 - 12/31/2023 Superseded View
Some older versions have been archived. Please visit the MCD Archive Site to retrieve them.

Keywords

N/A